,PDB,resolution,year,affinity,kd/ki,embedding_factor,complex_nha,lig_nha,distB,title,seq,TMScore,sess_id,distA,TMScore_Equil,dist_Equil,TMScore_MDinp,dist_MDinp
0,1mq5,2.1,2003,9.0,Ki=1nM,0.7939330355396929,2427,34,17.424027130828446,CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO-2-[[(4-CHLOROPHENYL) 2 AMINO]CARBONYL]PHENYL]-4-[(4-METHYL-1-PIPERAZINYL)METHYL]-2- 3 THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA,IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMK,0.9940823539443632,C4001MQ5,17.38449395510836,0.9940823539443632,17.172549305193968,0.9784905204479444,17.975523111563135
1,2idw,1.1,2006,8.89,Ki=1.3nM,0.8998886021574316,1803,38,4.884697378730111,CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT V82A WITH A POTEN 2 NON-PEPTIDE INHIBITOR (UIC-94017),PQITLWKRPLVTIKIGGQLKEALLDTGADDTVIEEMSLPGRWKPKMIGGIGGFIKVRQYDQIIIEIAGHKAIGTVLVGPTPANIIGRNLLTQIGATLNF,0.9929916343733438,C4002IDW,5.254564493534078,0.9929916343733438,4.899396022683176,0.9710975684279036,5.168215133245196
2,1swg,1.8,1998,7.36,Kd=43.9nM,0.8329395740465577,3812,16,15.243051847287257,CIRCULAR PERMUTED STREPTAVIDIN E51/A46 IN COMPLEX WITH BIOTIN,MESRYVLTGRYDSAPATDGSGTALGWTVAWKNNYRNAHSATTWSGQYVGGAEARINTQWLLTSGTTEANAWKSTLVGHDTFTKVKPSAASGGGSAEAGITGTWYNQLGSTFIVTAGADGALTGTYESA,0.8101084020432221,C4001SWG,15.0046169312231,0.8101084020432221,16.925868518812493,0.7862440761302254,17.096309901110267
3,1gpn,2.35,2002,6.48,Ki=0.334uM,0.9797910097640482,4442,19,7.8200090407098735,STRUCTURE OF ACETYLCHOLINESTERASE COMPLEXED WITH HUPERZINE B AT 2.35A 2 RESOLUTION,DDHSELLVNTKSGKVMGTRVPVLSSHISAFLGIPFAEPPVGNMRFRRPEPKKPWSGVWNASTYPNNCQQYVDEQFPGFSGSEMWNPNREMSEDCLYLNIWVPSPRPKSTTVMVWIYGGGFYSGSSTLDVYNGKYLAYTEEVVLVSLSYRVGAFGFLALHGSQEAPGNVGLLDQRMALQWVHDNIQFFGGDPKTVTIFGESAGGASVGMHILSPGSRDLFRRAILQSGSPNCPWASVSVAEGRRRAVELGRNLNCNLNSDEELIHCLREKKPQELIDVEWNVLPFDSIFRFSFVPVIDGEFFPTSLESMLNSGNFKKTQILLGVNKDEGSFFLLYGAPGFSKDSESKISREDFMSGVKLSVPHANDLGLDAVTLQYTDWMDDNNGIKNRDGLDDIVGDHNVICPLMHFVNKYTKFGNGTYLYFFNHRASNLVWPEWMGVIHGYEIEFVFGLPLVKELNYTAEEEALSRRIMHYWATFAKTGNPNEPHSQESKWPLFTTKEQKFIDLNTEPMKVHQRLRVQMCVFWNQFLPKLLNATAC,0.918616368111572,C4001GPN,9.749885680569124,0.918616368111572,9.823016191784411,0.9161411917631668,9.626940923676083
4,1ws4,1.9,2005,3.0,Kd=1.00mM,0.7098055031251429,4875,13,35.713115389295126,CRYSTAL STRUCTURE OF JACALIN- ME-ALPHA-MANNOSE COMPLEX: PROMISCUITY VS 2 SPECIFICITY,GKAFDDGAFTGIREINLSYNKETAIGDFQVVYDLNGSPYVGQNHVSFITGFTPVKISLDFPSEYIMEVSGYTGNVSGYVVVRSLTFKTNKKTYGPYGVTSGTPFNLPIENGLIVGFKGSIGYWLDYFSMYLSL,0.9943748757607204,C4001WS4,35.900462554143296,0.9943748757607204,35.5618164942391,0.9839865918032668,35.87477130190204
5,1lpz,2.4,2003,7.6,Ki=25nM,0.8239368452439393,2116,32,13.502681282457374,CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41.,EEMKKGHLERECMEETCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLER,0.9966816448335528,C4001LPZ,13.4018259924033,0.9966816448335528,13.64532296156351,0.0,999.0
6,1swr,1.9,1999,6.92,Kd=0.12uM,1.0127967286433963,3708,16,15.26454351234961,CORE-STREPTAVIDIN MUTANT W120A IN COMPLEX WITH BIOTIN AT PH 2 7.5,AEAGITGTWYNQLGSTFIVTAGADGALTGTYESAVGNAESRYVLTGRYDSAPATDGSGTALGWTVAWKNNYRNAHSATTWSGQYVGGAEARINTQWLLTSGTTEANAAKSTLVGHDTFTKVKPSAAS,0.6610772113443858,C4001SWR,404.3437113775602,0.6610772113443858,549.1360848772495,0.0,999.0
7,2a8g,1.99,2006,3.69,Kd=205uM,0.8661608350199298,3903,19,15.157853520764956,STRUCTURE OF AVIDIN IN COMPLEX WITH THE LIGAND DEOXYGUANOSINE,KCSLTGKWTNDLGSNMTIGAVNSRGEFTGTYTTAVTATSNEIKESPLHGTENTINKRTQPTFGFTVNWKFSESTTVFTGQCFIDRNGKEVLKTMWLLRSSVNDIGDDWKATRVGINIFTRLRTQKE,0.9832610612783258,C4002A8G,15.818062965769968,0.9832610612783258,15.801270631074788,0.0,999.0
8,1y3n,1.6,2005,5.55,Kd=2.8uM,0.9071553208017624,4704,24,6.172566187964076,"STRUCTURE OF ALGQ1, ALGINATE-BINDING PROTEIN, COMPLEXED WITH AN 2 ALGINATE DISACCHARIDE",REATWVTEKPLTLKIHMHFRDKWVWDENWPVAREVARLTNVKLVGVANRAATNSQEQFNLMMASGQLPDIVGGDNLKDKFIRYGMEGAFIPLNKLIDQNAPNLKAFFKTHPEVQRAITAPDGNIYYLPYVPDGLVSRGYFIRQDWLDKLHLKTPQTVDELYTVLKAFKEKDPNGNGKADEIPFINRDPEEVFRLVNFWGARSTGSNTWMDFYVENGKIKHPFAEVAFKDGIKHVAQWYKEGLIDPEIFTRKARSREQTFGNNIGGMTHDWFASTALFNDALSKNIPGFKLVPMAPPINSKGQRWEEDARQIPRPDGWAITATNKNPVETIKLFDFYFGPKGRELSNFGVPGLTYDIKNGKPVYKDTVLKAAQPVNNQMYDIGAQIPIGFWQDYEYERQWTNDVALQGIDMYIKNKYVLPQFTGVNLTVEEREIYDKYWPDVKTYMFEMGQSWVMGTKDPEKTWNDYQQQLKNRGFYQVMIVMQKAYDRQY,0.996461693883788,C4001Y3N,5.828982026905383,0.996461693883788,6.2616559900246695,0.9837427453441091,6.732168377083868
9,7std,1.8,1999,10.72,Ki=19pM,1.025595018367986,4453,20,17.803885951942867,SCYTALONE DEHYDRATASE PLUS INHIBITOR 4,GEITFSDYLGLMTCVYEWADSYDSKDWDRLRKVIAPTLRIDYRSFLDKLWEAMPAEEFVGMVSSKQVLGDPTLRTQHFIGGTRWEKVSEDEVIGYHQLRVPHQRYKDTTMKEVTMKGHAHSANLHWYKKIDGVWKFAGLKPDIRWGEFDFDRIFEDGRETFGDK,0.9932117245144608,C4007STD,17.730371911316418,0.9932117245144608,17.5130517170971,0.980243293089557,17.814028882602685
10,1fki,2.2,1994,7.0,Ki=100nM,0.6918881266383048,1806,31,20.09579608966118,"DESIGN, SYNTHESIS, AND KINETIC EVALUATION OF HIGH-AFFINITY FKBP 2 LIGANDS, AND THE X-RAY CRYSTAL STRUCTURES OF THEIR COMPLEXES WITH 3 FKBP12",GVQVETISPGDGRTFPKRGQTCVVHYTGMLEDGKKFDSSRDRNKPFKFMLGKQEVIRGWEEGVAQMSVGQRAKLTISPDYAYGATGHPGIIPPHATLVFDVELLKLE,0.598755738914032,C4001FKI,19.98738801876546,0.598755738914032,20.207166312178263,0.9611908562205123,20.950072839444257
11,1xk9,2.1,2005,6.85,Ki=140nM,0.6517867853726,1793,22,8.473042530443825,PSEUDOMANAS EXOTOXIN A IN COMPLEX WITH THE PJ34 INHIBITOR,EFLGDGGDVSFSTRGTQNWTVERLLQAHRQLEERGYVFVGYHGTFLEAAQSIVFGGVRARSQDLDAIWRGFYIAGDPALAYGYAQDQEPDARGRIRNGALLRVYVPRSSLPGFYRTSLTLAAPEAAGEVERLIGHPLPLRLDAITGPEEEGGRLETILGWPLAERTVVIPSAIPTDPRNVGGDLDPSSIPDKEQAISALPDYASQPGKPPREDLK,0.994531856892799,C4001XK9,8.21931292534514,0.994531856892799,11.258012621510955,0.9529186044485682,8.774797117595918
12,1uwf,1.69,2005,6.82,Kd=0.15uM,0.791989302249303,1519,16,22.218367620687737,1.7 A RESOLUTION STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF THE FIMH 2 ADHESIN FROM UROPATHOGENIC E. COLI,FACKTANGTAIPIGGGSANVYVNLAPVVNVGQNLVVDLSTQIFCHNDYPETITDYVTLQRGSAYGGVLSNFSGTVKYSGSSYPFPTTSETPRVVYNSRTDKPWPVALYLTPVSSAGGVAIKAGSLIAVLILRQTNNYNSDDFQFVWNIYANNDVVVPT,0.9947556142319448,C4001UWF,22.45892180272374,0.9947556142319448,20.98222191134382,0.9630301151294097,17.967947890878122
13,1qbo,1.8,2000,7.74,Ki=18nM,0.725959732211565,1816,34,13.877891243086127,BOVINE TRYPSIN 7-[[6-[[1-(1-IMINOETHYL)PIPERIDIN-4-YL]OXY]-2-METHYL- 2 BENZIMIDAZOL-1-YL]METHYL]NAPHTHALENE-2-CARBOXIMIDAMID ZK-806711 3 INHIBITOR COMPLEX,IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVVCSGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN,0.9955132096612346,C4001QBO,13.431528068887228,0.9955132096612346,13.44480554408006,0.9718020920236694,14.204526354642946
14,2jds,2.0,2007,8.2,Ki=6.3nM,0.8819359638995825,3302,30,8.918886488284917,STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH A- 2 443654,MGNAAAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIRVXINEKCGKEFSEF,0.9937850232996652,C4002JDS,9.038682292358592,0.9937850232996652,8.733083445147953,0.9789940137040882,8.874755138415429
15,2csn,2.5,1996,4.41,Ki=39uM,0.7487339485028781,5104,18,11.691472447993318,BINARY COMPLEX OF CASEIN KINASE-1 WITH CKI7,SGQNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL,0.9945621779634188,C4002CSN,11.917844049547488,0.9945621779634188,12.241117695787883,0.9726249901893118,12.12278786257618
16,2d0k,1.9,2006,5.02,Kd=9.51uM,0.670195175388787,1410,32,8.130452902226029,METHIONINE-FREE MUTANT OF ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE,AISLIAALAVDRVIGNENALPWNLPADLAWFKRNTLNKPVIYGRHTWESIGRPLPGRKNIILSSQPGTDDRVTWVKSVDEAIAAAGDVPEIFVIGGGRVYEQFLPKAQKLYLTHIDAEVEGDTHFPDYEPDDWESVFSEFHDADAQNSHSYSFEILERR,0.9912317969081276,C4002D0K,8.358229493196651,0.9912317969081276,20.977247751171813,0.9711824305173367,9.019704360505136
17,1b1h,1.8,1998,7.03,Kd=0.093uM,0.9903405618470652,4526,31,3.6857876775585527,OLIGO-PEPTIDE BINDING PROTEIN/TRIPEPTIDE (LYS HPE LYS) 2 COMPLEX,ADVPAGVQLADKQTLVRNNGSEVQSLDPHKIEGVPESNVSRDLFEGLLISDVEGHPSPGVAEKWENKDFKVWTFHLRENAKWSDGTPVTAHDFVYSWQRLADPNTASPYASYLQYGHIANIDDIIAGKKPATDLGVKALDDHTFEVTLSEPVPYFYKLLVHPSVSPVPKSAVEKFGDKWTQPANIVTNGAYKLKNWVVNERIVLERNPQYWDNAKTVINQVTYLPISSEVTDVNRYRSGEIDMTYNNMPIELFQKLKKEIPNEVRVDPYLCTYYYEINNQKAPFNDVRVRTALKLALDRDIIVNKVKNQGDLPAYSYTPPYTDGAKLVEPEWFKWSQQKRNEEAKKLLAEAGFTADKPLTFDLLYNTSDLHKKLAIAVASIWKKNLGVNVNLENQEWKTFLDTRHQGTFDVARAGWCADYNEPTSFLNTMLSDSSNNTAHYKSPAFDKLIADTLKVADDTQRSELYAKAEQQLDKDSAIVPVYYYVNARLVKPWVGGYTGKDPLDNIYVKNLYIIKH,0.9978478182689716,C4001B1H,3.5844448316119752,0.9978478182689716,3.6490655344848615,0.987738560857404,3.475768743912087
18,1q65,2.1,2004,5.46,Ki=3.5uM,0.730995006145933,3125,20,8.18141487516186,"CRYSTAL STRUCTURE OF TGT IN COMPLEX WITH 2,6-DIAMINO-8-(2- 2 DIMETHYLAMINOETHYLSULFANYLMETHYL)-3H-QUINAZOLIN-4-ONE CRYSTALLIZED A 3 PH 5.5",MVEATAQETDRPRFSFSIAAREGKARTGTIEMKRGVIRTPAFMPVGTAATVKALKPETVRATGADIILGNTYHLMLRPGAERIAKLGGLHSFMGWDRPILTDSGGYQVMSLSSLTKQSEEGVTFKSHLDGSRHMLSPERSIEIQHLLGSDIVMAFDECTPYPATPSRAASSMERSMRWAKRSRDAFDSRKEQAENAALFGIQQGSVFENLRQQSADALAEIGFDGYAVGGLAVGEGQDEMFRVLDFSVPMLPDDKPHYLMGVGKPDDIVGAVERGIDMFDCVLPTRSGRNGQAFTWDGPINIRNARFSEDLKPLDSECHCAVCQKWSRAYIHHLIRAGEILGAMLMTEHNIAFYQQLMQKIRDSISEGRFSQFAQDFRARYFARNS,0.7250320077769847,C4001Q65,22.81465012048198,0.7250320077769847,22.00680981301619,0.0,999.0
19,1ocq,1.08,2003,5.19,Ki=6.5uM,0.8216927036301246,2820,21,13.291416542104054,COMPLEX OF THE ENDOGLUCANASE CEL5A FROM BACILLUS AGARADHEARANS AT 1.08 2 ANGSTROM RESOLUTION WITH CELLOBIO-DERIVED ISOFAGOMINE,DNDSVVEEHGQLSISNGELVNERGEQVQLKGMSSHGLQWYGQFVNYESMKWLRDDWGINVFRAAMYTSSGGYIDDPSVKEKVKEAVEAAIDLDIYVIIDWHILSDNDPNIYKEEAKDFFDEMSELYGDYPNVIYEIANEPNGSDVTWGNQIKPYAEEVIPIIRNNDPNNIIIVGTGTWSQDVHHAADNQLADPNVMYAFHFYAGTHGQNLRDQVDYALDQGAAIFVSEWGTSAATGDGGVFLDEAQVWIDFMDERNLSWANWSLTHKDESSAALMPGANPTGGWTEAELSPSGTFVREKIRES,0.9943164677003136,C4001OCQ,13.157541185266773,0.9943164677003136,13.080685436015374,0.0,999.0
20,2d3z,1.8,2006,6.64,Ki=0.23uM,0.7447741823354611,4999,26,27.84475701448862,X-RAY CRYSTAL STRUCTURE OF HEPATITIS C VIRUS RNA-DEPENDENT 2 RNA POLYMERASE IN COMPLEX WITH NON-NUCLEOSIDE ANALOGUE 3 INHIBITOR,SMSYTWTGALITPCAAEESKLPINALSNSLLRHHNMVYATTSRSAGLRQKKVTFDRLQVLDDHYRDVLKEMKAKASTVKAKLLSVEEACKLTPPHSAKSKFGYGAKDVRNLSSKAVNHIHSVWKDLLEDTVTPIDTTIMAKNEVFCVQPEKGGRKPARLIVFPDLGVRVCEKMALYDVVSTLPQVVMGSSYGFQYSPGQRVEFLVNTWKSKKNPMGFSYDTRCFDSTVTENDIRVEESIYQCCDLAPEARQAIKSLTERLYIGGPLTNSKGQNCGYRRCRASGVLTTSCGNTLTCYLKASAACRAAKLQDCTMLVNGDDLVVICESAGTQEDAASLRVFTEAMTRYSAPPGDPPQPEYDLELITSCSSNVSVAHDASGKRVYYLTRDPTTPLARAAWETARHTPVNSWLGNIIMYAPTLWARMILMTHFFSILLAQEQLEKALDCQIYGACYSIEPLDLPQIIERLHGLSAFSLHSYSPGEINRVASCLRKLGVPPLRVWRHRARSVRARLLSQGGRAATCGKYLFNWAVKTKLKLTPIPAASQLDLSGWFVAGYSGGDIYHSLSRARPR,0.7469219121609029,C4002D3Z,20.807268781664344,0.7469219121609029,33.55405576439084,0.0,999.0
21,3b68,1.9,2008,8.4,Ki=4nM,1.042534069444395,2191,31,8.313342468129184,CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING 2 DOMAIN IN COMPLEX WITH SARM S-4,PIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ,0.9948761981149684,C4003B68,8.179234289146455,0.9948761981149684,8.281964693508408,0.9648035752934281,8.249723555079646
22,1b05,2.0,1998,7.12,Kd=75nM,0.9780281508680388,4369,25,3.075113266192252,STRUCTURE OF OLIGO-PEPTIDE BINDING PROTEIN COMPLEXED WITH 2 LYS-CYS-LYS,ADVPAGVQLADKQTLVRNNGSEVQSLDPHKIEGVPESNVSRDLFEGLLISDVEGHPSPGVAEKWENKDFKVWTFHLRENAKWSDGTPVTAHDFVYSWQRLADPNTASPYASYLQYGHIANIDDIIAGKKPATDLGVKALDDHTFEVTLSEPVPYFYKLLVHPSVSPVPKSAVEKFGDKWTQPANIVTNGAYKLKNWVVNERIVLERNPQYWDNAKTVINQVTYLPISSEVTDVNRYRSGEIDMTYNNMPIELFQKLKKEIPNEVRVDPYLCTYYYEINNQKAPFNDVRVRTALKLALDRDIIVNKVKNQGDLPAYSYTPPYTDGAKLVEPEWFKWSQQKRNEEAKKLLAEAGFTADKPLTFDLLYNTSDLHKKLAIAVASIWKKNLGVNVNLENQEWKTFLDTRHQGTFDVARAGWCADYNEPTSFLNTMLSDSSNNTAHYKSPAFDKLIADTLKVADDTQRSELYAKAEQQLDKDSAIVPVYYYVNARLVKPWVGGYTGKDPLDNIYVKNLYIIKH,0.997449884490792,C4001B05,2.932028042128513,0.997449884490792,2.8822392671325163,0.9829600647055501,4.150252694623686
23,1o5a,1.68,2004,6.42,Ki=0.38uM,0.7692210048102619,2134,25,10.229322417892192,DISSECTING AND DESIGNING INHIBITOR SELECTIVITY DETERMINANTS AT THE S1 2 SITE USING AN ARTIFICIAL ALA190 PROTEASE (ALA190 UPA),KPSSPPEELKFQCGQKTLRPRFK,0.9955603209612156,C4001O5A,10.22963891513334,0.9955603209612156,11.129162676733936,0.9785033505406666,11.446376352503096
24,2o4j,1.74,2007,10.1,Ki=0.08nM,0.9842952121711152,2152,30,8.704929265353163,CRYSTAL STRUCTURE OF RAT VITAMIN D RECEPTOR LIGAND BINDING DOMAIN 2 COMPLEXED WITH VITIII 17-20Z AND THE NR2 BOX OF DRIP 205,LKDSLRPKLSEEQQHIIAILLDAHHKTYDPTYADFRDFRPPVRMDGSTGSVTLDLSPLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSDDQIVLLKSSAIEVIMLRSNQSFTMDDMSWDCGSQDYKYDVTDVSKAGHTLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAKLVEAIQDRLSNTLQTYIRCRHPPPGSHQLYAKMIQKLADLRSLNEEHSKQYRSLSFQPENSMKLTPLVLEVFGNEISLVPRGSMAISDPNSSSVDKLAAALEHHHHHH,0.827889221492078,C4002O4J,154.24480043536795,0.827889221492078,267.1726941203569,0.0,999.0
25,2br1,2.0,2005,5.14,Ki=7.2uM,0.6499254285675498,2539,29,13.184542136595033,STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS 2 INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY,MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGHHHHHHHH,0.8432167945162818,C4002BR1,26.37447073037092,0.8432167945162818,27.31591617362265,0.0,999.0
26,3bgq,2.0,2007,7.96,Ki=11nM,0.7935794780912684,2359,26,11.038514797827553,HUMAN PIM-1 KINASE IN COMPLEX WITH AN TRIAZOLO PYRIDAZINE 2 INHIBITOR VX2,MGSSHHHHHHSSGLVPRGSHMLLSKINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK,0.959253768763238,C4003BGQ,12.127175363574688,0.959253768763238,12.705323793053347,0.9395293921558933,11.931457645765015
27,2flr,2.35,2007,6.1,Ki=0.8uM,0.7431232559839367,4288,27,25.420591626645123,NOVEL 5-AZAINDOLE FACTOR VIIA INHIBITORS,ANAFLEELRPGSLERECKEEQCSFEEAREIFKDAERTKLFWISYSDGDQCASSPCQNGGSCKDQLQSYICFCLPAFEGRNCETHKDDQLICVNENGGCEQYCSDHTGTKRSCRCHEGYSLLADGVSCTPTVEYPCGKIPILEKRNASKPQGR,0.7298079367299932,C4002FLR,27.49889900108523,0.7298079367299932,27.562013392309595,0.0,999.0
28,1eld,2.0,1995,6.7,Ki=0.20uM,0.6948133720791486,1989,33,13.022031319691544,STRUCTURAL ANALYSIS OF THE ACTIVE SITE OF PORCINE PANCREATIC ELASTASE 2 BASED ON THE X-RAY CRYSTAL STRUCTURES OF COMPLEXES WITH 3 TRIFLUOROACETYL-DIPEPTIDE-ANILIDE INHIBITORS,VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCVDRELTFRVVVGEHNLNQNNGTEQYVGVQKIVVHPYWNTDDVAAGYDIALLRLAQSVTLNSYVQLGVLPRAGTILANNSPCYITGWGLTRTNGQLAQTLQQAYLPTVDYAICSSSSYWGSTVKNSMVCAGGDGVRSGCQGDSGGPLHCLVNGQYAVHGVTSFVSRLGCNVTRKPTVFTRVSAYISWINNVIASN,0.9946707111865636,C4001ELD,13.107546291560752,0.9946707111865636,13.137367334110497,0.9676874837802211,12.937911934750028
29,3d0b,1.74,2008,6.54,Kd=0.29uM,0.8047852572189582,1945,28,5.59415400843362,CRYSTAL STRUCTURE OF BENZAMIDE TETRAHYDRO-4H-CARBAZOL-4-ONE 2 BOUND TO HSP90,MPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSD,0.532802802603159,C4003D0B,23.07322606370914,0.532802802603159,23.111751137399512,0.0,999.0
30,3b67,1.9,2008,8.85,Ki=1.4nM,1.019740456689478,2225,32,8.30780914318143,CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING 2 DOMAIN IN COMPLEX WITH SARM C-23,PIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ,0.9943925493088008,C4003B67,8.44333722266369,0.9943925493088008,8.24144201922135,0.9854491678217588,8.809891697291134
31,2qe4,2.4,2007,7.96,Ki=11.0nM,0.9782238167375872,3329,24,19.22049263941499,ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A 2 BENZOPYRAN AGONIST,NSLALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKSKNVVPLYDLLLEMLDAHRLHA,0.9916156806605544,C4002QE4,54.05517459270817,0.9916156806605544,19.477271348521384,0.9789638147433163,19.44969087393623
32,1y6q,2.2,2005,11.7,Ki=2pM,1.0455643140530382,3674,20,15.581791735636465,CYRSTAL STRUCTURE OF MTA/ADOHCY NUCLEOSIDASE COMPLEXED WITH 2 MT-DADME-IMMA,FQGAMDPEFSMKIGIIGAMEEEVTLLRDKIENRQTISLGGCEIYTGQLNGTEVALLKSGIGKVAAALGATLLLEHCKPDVIINTGSAGGLAPTLKVGDIVVSDEARYHDADVTAFGYEYGQLPGCPAGFKADDKLIAAAEACIAELNLNAVRGLIVSGDAFINGSVGLAKIRHNFPQAIAVEMEATAIAHVCHNFNVPFVVVRAISDVADQQSHLSFDEFLAVAAKQSSLMVESLVQKLAHG,0.995306381293549,C4001Y6Q,15.384277748077093,0.995306381293549,15.92160605316975,0.0,999.0
33,1f4g,1.75,2000,6.48,Ki=330nM,0.7670272976376451,4816,34,20.47423896467312,CRYSTAL STRUCTURE OF E. COLI THYMIDYLATE SYNTHASE COMPLEXED WITH SP- 2 876,XKQYLELMQKVLDEGTQKNDRTGTGTLSIFGHQMRFNLQDGFPLVTTKRCHLRSIIHELLWFLQGDTNIAYLHENNVTIWDEWADENGDLGPVYGKQWRAWPTPDGRHIDQITTVLNQLKNDPDSRRIIVSAWNVGELDKMALAPCHAFFQFYVADGKLSCQLYQRSCDVFLGLPFNIASYALLVHMXAQQCDLEVGDFVWTGGDTHLYSNHMDQTHLQLSREPRPLPKLIIKRKPESIFDYRFEDFEIEGYDPHPGIKAPVAI,0.8095576060060519,C4001F4G,20.963174705402142,0.8095576060060519,504.5548830548647,0.0,999.0
34,1hms,1.4,1995,6.37,Kd=0.43uM,0.7412284302621752,1273,20,7.002731164769845,1.4 ANGSTROMS STRUCTURAL STUDIES ON HUMAN MUSCLE FATTY ACID BINDING 2 PROTEIN: BINDING INTERACTIONS WITH THREE SATURATED AND UNSATURATED 3 C18 FATTY ACIDS,VDAFLGTWKLVDSKNFDDYMKSLGVGFATRQVASMTKPTTIIEKNGDILTLKTHSTFKNTEISFKLGVEFDETTADDRKVKSIVTLDGGKLVHLQKWDGQETTLVRELIDGKLILTLTHGTAVCTRTYEKEA,0.9894508623927366,C4001HMS,6.284337974179356,0.9894508623927366,7.507216618648489,0.9712374267451136,6.969768936787873
35,2gv6,2.1,2006,7.34,Ki=46nM,0.5502253533452939,2146,39,13.756219253692755,CRYSTAL STRUCTURE OF MATRIPTASE WITH INHIBITOR CJ-730,VVGGTDADEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQWTAFLGLHDQSQRSAPGVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPICLPDASHVFPAGKAIWVTGWGHTQYGGTGALILQKGEIRVINQTTCENLLPQQITPRMMCVGFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWIKENTGV,0.996424145675825,C4002GV6,13.802915094952692,0.996424145675825,12.436419995797584,0.9756269993694594,13.887738762216124
36,1dhi,1.9,1994,7.26,Kd=55nM,0.691543470790378,2917,33,10.244624208349856,LONG-RANGE STRUCTURAL EFFECTS IN A SECOND-SITE REVERTANT OF A MUTANT 2 DIHYDROFOLATE REDUCTASE,MISLIAALAVDRVIGMENAMPWNLPASLAWFKRNTLDKPVIMGRHTWESIGRPLPGRKNIILSSQPGTDDRVTWVKSVDEAIAACGDVPEIMVIGGGRVYEQFLPKAQKLYLTHIDAEVEGDTHFPDYEPDDWESVFSEFHDADAQNSHSYCFEILERR,0.0,C4001DHI,10.277627932902703,0.0,999.0,0.9872854509494509,10.468089336553742
37,1erb,1.9,1994,8.1,Kd=8nM,0.929641602780923,1585,24,9.153362234413596,THE INTERACTION OF N-ETHYL RETINAMIDE WITH PLASMA RETINOL-BINDING 2 PROTEIN (RBP) AND THE CRYSTAL STRUCTURE OF THE RETINOID-RBP COMPLEX 3 AT 1.9 ANGSTROMS RESOLUTION,ERDCRVSSFRVKENFDKARFAGTWYAMAKKDPEGLFLQDNIVAEFSVDENGHMSATAKGRVRLLNNWDVCADMVGTFTDTEDPAKFKMKYWGVASFLQKGNDDHWIIDTDYETFAVQYSCRLLNLDGTCADSYSFVFARDPSGFSPEVQKIVRQRQEELCLARQYRLIPHNGYCDGKSERNIL,0.99415203654828,C4001ERB,17.251165644411508,0.99415203654828,65.32325486831434,0.960911229033098,23.745191442275168
38,2f80,1.45,2006,8.18,Ki=6.6nM,0.9405569136271752,1749,38,5.019715086156805,HIV-1 PROTEASE MUTANT D30N COMPLEXED WITH INHIBITOR TMC114,PQITLWKRPLVTIKIGGQLKEALLDTGADNTVIEEMSLPGRWKPKMIGGIGGFIKVRQYDQIIIEIAGHKAIGTVLVGPTPVNIIGRNLLTQIGATLNF,0.99321280334414,C4002F80,5.219714741976369,0.99321280334414,27.42299415382108,0.9807577023749259,4.7698966525505195
39,1fh9,1.72,2000,6.43,Ki=0.37uM,0.8520987245834346,2690,20,8.726555075963724,CRYSTAL STRUCTURE OF THE XYLANASE CEX WITH XYLOBIOSE-DERIVED LACTAM 2 OXIME INHIBITOR,ATTLKEAADGAGRDFGFALDPNRLSEAQYKAIADSEFNLVVAENAMKWDATEPSQNSFSFGAGDRVASYAADTGKELYGHTLVWHSQLPDWAKNLNGSAFESAMVNHVTKVADHFEGKVASWDVVNEAFADGGGRRQDSAFQQKLGNGYIETAFRAARAADPTAKLCINDYNVEGINAKSNSLYDLVKDFKARGVPLDCVGFQSHLIVGQVPGDFRQNLQRFADLGVDVRITELDIRMRTPSDATKLATQAADYKKVVQACMQVTRCQGVTVWGITDKYSWVPDVFPGEGAALVWDASYAKKPAYAAVMEAF,0.9961522237131192,C4001FH9,8.734687225510156,0.9961522237131192,9.31568506240262,0.0,999.0
40,1fcy,1.3,2000,8.52,Kd=3nM,1.031290434124131,2192,29,8.505449925800143,ISOTYPE SELECTIVITY OF THE HUMAN RETINOIC ACID NUCLEAR RECEPTOR HRAR: 2 THE COMPLEX WITH THE RARBETA/GAMMA-SELECTIVE RETINOID CD564,ASPQLEELITKVSKAHQETFPSLCQLGKYTTNSSADHRVQLDLGLWDKFSELATKCIIKIVEFAKRLPGFTGLSIADQITLLKAACLDILMLRICTRYTPEQDTMTFSDGLTLNRTQMHNAGFGPLTDLVFAFAGQLLPLEMDDTETGLLSAICLICGDRMDLEEPEKVDKLQEPLLEALRLYARRRRPSQPYMFPRMLMKITDLRGISTKGAERAITLKMEIPGPMPPLIREMLE,0.9903665268103958,C4001FCY,8.941373643156071,0.9903665268103958,8.381270115355916,0.9755987373552416,8.526272142831884
41,1ela,2.0,1994,6.36,Ki=0.44uM,0.6126117159842361,2021,32,13.103090952527054,ANALOGOUS INHIBITORS OF ELASTASE DO NOT ALWAYS BIND ANALOGOUSLY,VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCVDRELTFRVVVGEHNLNQNNGTEQYVGVQKIVVHPYWNTDDVAAGYDIALLRLAQSVTLNSYVQLGVLPRAGTILANNSPCYITGWGLTRTNGQLAQTLQQAYLPTVDYAICSSSSYWGSTVKNSMVCAGGDGVRSGCQGDSGGPLHCLVNGQYAVHGVTSFVSRLGCNVTRKPTVFTRVSAYISWINNVIASN,0.9956736687608332,C4001ELA,13.067666600623571,0.9956736687608332,13.249334940378594,0.9750677064989997,13.65506471288983
42,1f4e,1.9,2000,2.96,Ki=1.1mM,0.7350544096552406,4736,18,18.68505909721074,CRYSTAL STRUCTURE OF E. COLI THYMIDYLATE SYNTHASE COMPLEXED WITH 2 TOSYL-D-PROLINE,XKQYLELMQKVLDEGTQKNDRTGTGTLSIFGHQMRFNLQDGFPLVTTKRCHLRSIIHELLWFLQGDTNIAYLHENNVTIWDEWADENGDLGPVYGKQWRAWPTPDGRHIDQITTVLNQLKNDPDSRRIIVSAWNVGELDKMALAPCHAFFQFYVADGKLSCQLYQRSCDVFLGLPFNIASYALLVHMMAQQCDLEVGDFVWTGGDTHLYSNHMDQTHLQLSREPRPLPKLIIKRKPESIFDYRFEDFEIEGYDPHPGIKAPVAI,0.9947047888297244,C4001F4E,18.98857655055448,0.9947047888297244,18.91210055270116,0.9810192766111698,18.625087054854298
43,2j7e,2.19,2006,7.32,Kd=48nM,0.8313986973090879,3897,19,6.141058273950343,BETA-GLUCOSIDASE FROM THERMOTOGA MARITIMA IN COMPLEX WITH 2 METHYL ACETATE-SUBSTITUTED GLUCOIMIDAZOLE,MGSSHHHHHHSSGLVPRGSHMASNVKKFPEGFLWGVATASYQIEGSPLADGAGMSIWHTFSHTPGNVKNGDTGDVACDHYNRWKEDIEIIEKLGVKAYRFSISWPRILPEGTGRVNQKGLDFYNRIIDTLLEKGITPFVTIYHWDLPFALQLKGGWANREIADWFAEYSRVLFENFGDRVKNWITLNEPWVVAIVGHLYGVHAPGMRDIYVAFRAVHNLLRAHARAVKVFRETVKDGKIGIVFNNGYFEPASEKEEDIRAVRFMHQFNNYPLFLNPIYRGDYPELVLEFAREYLPENYKDDMSEIQEKIDFVGLNYYSGHLVKFDPDAPAKVSFVERDLPKTAMGWEIVPEGIYWILKKVKEEYNPPEVYITENGAAFDDVVSEDGRVHDQNRIDYLKAHIGQAWKAIQEGVPLKGYFVWSLLDNFEWAEGYSKRFGIVYVDYSTQKRIVKDSGYWYSNVVKNNGLED,0.524421684481673,C4002J7E,22.73746246749204,0.524421684481673,22.965247846983765,0.0,999.0
44,1k21,1.86,2002,8.38,Ki=4.2nM,0.8148241453434911,2514,31,14.322920999348328,HUMAN THROMBIN-INHIBITOR COMPLEX,TFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGR,0.6759386542357824,C4001K21,18.049792829934443,0.6759386542357824,18.351243788692365,0.0,999.0
45,1jet,1.2,1997,7.25,Kd=56nM,0.9906286919125152,4757,24,2.9774802653094,OLIGO-PEPTIDE BINDING PROTEIN (OPPA) COMPLEXED WITH KAK,ADVPAGVQLADKQTLVRNNGSEVQSLDPHKIEGVPESNVSRDLFEGLLISDVEGHPSPGVAEKWENKDFKVWTFHLRENAKWSDGTPVTAHDFVYSWQRLADPNTASPYASYLQYGHIANIDDIIAGKKPATDLGVKALDDHTFEVTLSEPVPYFYKLLVHPSVSPVPKSAVEKFGDKWTQPANIVTNGAYKLKNWVVNERIVLERNPQYWDNAKTVINQVTYLPISSEVTDVNRYRSGEIDMTYNNMPIELFQKLKKEIPNEVRVDPYLCTYYYEINNQKAPFNDVRVRTALKLALDRDIIVNKVKNQGDLPAYSYTPPYTDGAKLVEPEWFKWSQQKRNEEAKKLLAEAGFTADKPLTFDLLYNTSDLHKKLAIAVASIWKKNLGVNVNLENQEWKTFLDTRHQGTFDVARAGWCADYNEPTSFLNTMLSDSSNNTAHYKSPAFDKLIADTLKVADDTQRSELYAKAEQQLDKDSAIVPVYYYVNARLVKPWVGGYTGKDPLDNIYVKNLYIIKH,0.99838508754981,C4001JET,2.966509123267311,0.99838508754981,3.192892186232149,0.9888398643269165,3.8611868993654643
46,2drc,1.9,1994,9.89,Kd=0.13nM,0.7288516961976559,2584,33,10.162734676800738,INVESTIGATION OF THE FUNCTIONAL ROLE OF TRYPTOPHAN-22 IN ESCHERICHIA 2 COLI DIHYDROFOLATE REDUCTASE BY SITE-DIRECTED MUTAGENESIS,MISLIAALAVDRVIGMENAMPFNLPADLAWFKRNTLDKPVIMGRHTWESIGRPLPGRKNIILSSQPGTDDRVTWVKSVDEAIAACGDVPEIMVIGGGRVYEQFLPKAQKLYLTHIDAEVEGDTHFPDYEPDDWESVFSEFHDADAQNSHSYCFEILERR,0.989623131114376,C4002DRC,10.486739722765334,0.989623131114376,10.727011050417817,0.9682376802131542,10.117563359442155
47,1k22,1.93,2002,8.4,Ki=4nM,0.8572912261829145,2538,31,14.310724448416003,HUMAN THROMBIN-INHIBITOR COMPLEX,TFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGR,0.443539185512269,C4001K22,30.199667763995013,0.443539185512269,618.3481990442647,0.0,999.0
48,1hmr,1.4,1995,6.55,Kd=0.28uM,0.7549712711322125,1271,20,6.839213997053282,1.4 ANGSTROMS STRUCTURAL STUDIES ON HUMAN MUSCLE FATTY ACID BINDING 2 PROTEIN: BINDING INTERACTIONS WITH THREE SATURATED AND UNSATURATED 3 C18 FATTY ACIDS,VDAFLGTWKLVDSKNFDDYMKSLGVGFATRQVASMTKPTTIIEKNGDILTLKTHSTFKNTEISFKLGVEFDETTADDRKVKSIVTLDGGKLVHLQKWDGQETTLVRELIDGKLILTLTHGTAVCTRTYEKEA,0.9880031205024618,C4001HMR,7.140124366899796,0.9880031205024618,6.990920240010301,0.9697151888025317,6.416091722443612
49,1p57,1.75,2004,4.4,Ki=40uM,0.7643110565082354,3009,19,20.117448604738904,EXTRACELLULAR DOMAIN OF HUMAN HEPSIN,SDQEPLYPVQVSSADARLMVFDKTEGTWRLLCSSRSNARVAGLSCEEMGFLRALTHSELDVRTAGAAGTSGFFCVDEGRLPHTQRLLEVISVCDCPRGRFLAAICQDCGRRKLP,0.5748156539254885,C4001P57,20.40794971582116,0.5748156539254885,17.120272057347375,0.0,999.0
50,3gst,1.9,1993,6.72,Ki=0.19uM,0.8065652736536669,4108,35,11.811041182969923,"STRUCTURE OF THE XENOBIOTIC SUBSTRATE BINDING SITE OF A GLUTATHIONE S- 2 TRANSFERASE AS REVEALED BY X-RAY CRYSTALLOGRAPHIC ANALYSIS OF PRODUC 3 COMPLEXES WITH THE DIASTEREOMERS OF 9-(S-GLUTATHIONYL)-10-HYDROXY-9, 4 10-DIHYDROPHENANTHRENE",PMILGYWNVRGLTHPIRLLLEYTDSSYEEKRYAMGDAPDYDRSQWLNEKFKLGLDFPNLPYLIDGSRKITQSNAIMRYLARKHHLCGETEEERIRADIVENQVMDNRMQLIMLCYNPDFEKQKPEFLKTIPEKMKLYSEFLGKRPWFAGDKVTYVDFLAYDILDQYHIFEPKCLDAFPNLKDFLARFEGLKKISAYMKSSRYLSTPIFSKLAQWSNK,0.9971124532467897,C4003GST,11.80023764645128,0.9971124532467897,11.94178881440979,0.9841350243468932,11.548002985205537
51,1lbk,1.86,2002,3.18,Kd=668uM,0.7605191433087121,3742,20,13.727024906472176,"CRYSTAL STRUCTURE OF A RECOMBINANT GLUTATHIONE TRANSFERASE, CREATED BY 2 REPLACING THE LAST SEVEN RESIDUES OF EACH SUBUNIT OF THE HUMAN CLASS 3 PI ISOENZYME WITH THE ADDITIONAL C-TERMINAL HELIX OF HUMAN CLASS 4 ALPHA ISOENZYME",PPYTVVYFPVRGRCAALRMLLADQGQSWKEEVVTVETWQEGSLKASCLYGQLPKFQDGDLTLYQSNTILRHLGRTLGLYGKDQQEAALVDMVNDGVEDLRCKYISLIYTNYEAGKDDYVKALPGQLKPFETLLSQNQGGKTFIVGDQISFADYNLLDLLLIHEVLAPGCLDAFPLLSAYVGRLSARPKLKAFLASPEYVNLPMDEKSL,0.9912769115889104,C4001LBK,12.237863144509236,0.9912769115889104,20.498477990732702,0.9828751200062795,11.981934261011673
52,1pzi,1.99,2004,4.22,Kd=60uM,0.6590907603181357,4718,23,27.289716741878127,HEAT-LABILE ENTEROTOXIN B-PENTAMER COMPLEXED WITH NITROPHENYL 2 GALACTOSIDE 2A,APQTITELCSEYRNTQIYTINDKILSYTESMAGKREMVIITFKSGETFQVEVPGSQHIDSQKKAIERMKDTLRITYLTETKIDKLCVWNNKTPNSIAAISMKN,0.9968872616002116,C4001PZI,27.315554363187346,0.9968872616002116,27.697576059627423,0.9859134549521372,28.062997123438098
53,1e2k,1.7,2000,4.94,Ki=11.4uM,1.0675693327974276,5141,18,18.21891128897392,KINETICS AND CRYSTAL STRUCTURE OF THE WILD-TYPE AND THE ENGINEERED 2 Y101F MUTANT OF HERPES SIMPLEX VIRUS TYPE 1 THYMIDINE KINASE 3 INTERACTING WITH (NORTH)-METHANOCARBA-THYMIDINE,MPTLLRVYIDGPHGMGKTTTTQLLVALGSRDDIVYVPEPMTYWRVLGASETIANIYTTQHRLDQGEISAGDAAVVMTSAQITMGMPYAVTDAVLAPHIGGEAGSSHAPPPALTLIFDRHPIAALLCYPAARYLMGSMTPQAVLAFVALIPPTLPGTNIVLGALPEDRHIDRLAKRQRPGERLDLAMLAAIRRVYGLLANTVRYLQCGGSWREDWGQLSGTAVPPQGAEPQSNAGPRPHIGDTLFTLFRAPELLAPNGDLYNVFAWALDVLAKRLRSMHVFILDYDQSPAGCRDALLQLTSGMVQTHVTTPGSIPTICDLARTFAREMGEAN,0.9935240679449936,C4001E2K,42.52403628390557,0.9935240679449936,17.353558061635464,0.9833902145610699,18.054007519164013
54,3bgb,1.9,2008,6.05,Ki=0.9uM,0.937242923143752,1662,35,5.429304091840052,HIV-1 PROTEASE IN COMPLEX WITH A ISOBUTYL DECORATED 2 OLIGOAMINE,PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYDQILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF,0.9951702162103891,C4003BGB,5.360603260235999,0.9951702162103891,5.24571311293981,0.9656082769522513,4.564960392424167
55,5er1,2.0,1991,6.02,Ki=960nM,0.6848582716364389,2754,37,10.922263603710013,A RATIONAL APPROACH TO THE DESIGN OF ANTIHYPERTENSIVES. X-RAY STUDIES 2 OF COMPLEXES BETWEEN ASPARTIC PROTEINASES AND AMINOALCOHOL RENIN 3 INHIBITORS,STGSATTTPIDSLDDAYITPVQIGTPAQTLNLDFDTGSSDLWVFSSETTASEVDGQTIYTPSKSTTAKLLSGATWSISYGDGSSSSGDVYTDTVSVGGLTVTGQAVESAKKVSSSFTEDSTIDGLLGLAFSTLNTVSPTQQKTFFDNAKASLDSPVFTADLGYHAPGTYNFGFIDTTAYTGSITYTAVSTKQGFWEWTSTGYAVGSGTFKSTSIDGIADTGTTLLYLPATVVSAYWAQVSGAKSSSSVGGYVFPCSATLPSFTFGVGSARIVIPGDYIDFGPISTGSSSCFGGIQSSAGIGINIFGDVALKAAFVVFNGATTPTLGFASK,0.981871192432352,C4005ER1,10.659906062334056,0.981871192432352,11.876707015140596,0.9569465623456914,11.144004845365112
56,3bex,1.51,2008,5.57,Kd=2.7uM,0.9612095713225046,4458,15,15.522907884281068,TYPE III PANTOTHENATE KINASE FROM THERMOTOGA MARITIMA 2 COMPLEXED WITH PANTOTHENATE REVDAT   2   01-JUL-08 3BEX    1       TITLE,MDPMYLLVDVGNTHSVFSITEDGKTFRRWRLSTGVFQTEDELFSHLHPLLGDAMREIKGIGVASVVPTQNTVIERFSQKYFHISPIWVKAKNGCVKWNVKNPSEVGADRVANVVAFVKEYGKNGIIIDMGTATTVDLVVNGSYEGGAILPGFFMMVHSLFRGTAKLPLVEVKPADFVVGKDTEENIRLGVVNGSVYALEGIIGRIKEVYGDLPVVLTGGQSKIVKDMIKHEIFDEDLTIKGVYHFCFGD,0.9845332428677702,C4003BEX,15.445809351270771,0.9845332428677702,14.286845793593791,0.9814996037521055,14.357527266275213
57,1ogz,2.3,2003,5.85,Kd=1.4uM,0.7857967598574451,2094,20,15.399712418172708,CRYSTAL STRUCTURE OF 5-3-KETOSTEROID ISOMERASE MUTANTS P39A 2 COMPLEXED WITH EQUILENIN FROM PSEUDOMONAS TESTOSTERONI,MNTPEHMTAVVQRYVAALNAGDLDGIVALFADDATVEDAVGSEPRSGTAAIREFYANSLKLPLAVELTQEVRAVANEAAFAFIVSFEYQGRKTVVAPIDHFRFNGAGKVVSMRALFGEKNIHAGA,0.9920535799490058,C4001OGZ,15.990222491734462,0.9920535799490058,15.723679685109486,0.0,999.0
58,1owh,1.61,2003,7.4,Ki=40nM,0.7271056448014279,2128,24,11.095852539905255,SUBSTITUTED 2-NAPHTHAMIDINE INHIBITORS OF UROKINASE,IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT,0.9940386829209954,C4001OWH,10.753141625303348,0.9940386829209954,28.06106234958633,0.9809726960514624,10.946172135598905
59,1ugx,1.6,2003,5.91,Kd=1.24uM,0.5309814025957778,5079,27,34.33404570570669,CRYSTAL STRUCTURE OF JACALIN- ME-ALPHA-T-ANTIGEN (GAL-BETA(1-3)- 2 GALNAC-ALPHA-O-ME) COMPLEX,GKAFDDGAFTGIREINLSYNKETAIGDFQVVYDLNGSPYVGQNHVSFITGFTPVKISLDFPSEYIMEVSGYTGNVSGYVVVRSLTFKTNKKTYGPYGVTSGTPFNLPIENGLIVGFKGSIGYWLDYFSMYLSL,0.994437433708746,C4001UGX,34.51274170570947,0.994437433708746,35.50144035082998,0.0,999.0
60,2oxx,2.3,2007,6.7,Ki=0.20uM,0.7715578597344734,2846,14,14.522203685424834,"PROTEIN KINASE CK2 IN COMPLEX WITH TETRABROMOBENZOIMIDAZOLE 2 DERIVATIVES K17, K22 AND K32",MSKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQVRAAENSRTRA,0.9963962417823732,C4002OXX,14.233121179131624,0.9963962417823732,13.956419062707834,0.9737512092116819,13.846362040247534
61,3f8c,2.2,2008,7.68,Kd=21nM,0.6427875302058994,1784,34,0.5691332370756196,CRYSTAL STRUCTURE OF MULTIDRUG BINDING TRANSCRIPTIONAL REGULATOR LMRR 2 COMPLEXED WITH HOECHST 33342,MAEIPKEMLRAQTNVILLNVLKQGDNYVYGIIKQVKEASNGEMELNEATLYTIFKRLEKDGIISSYWGDESQGGRRKYYRLTEIGHENMRLAFESWSRVDKIIENLEANKKSEAIKSRWSHPQFEK,0.3296489591507694,C4003F8C,9.80222943216244,0.3296489591507694,4.014678416625881,0.0,999.0
62,3djk,1.0,2008,10.59,Ki=26pM,0.9467173572867408,1762,38,5.023030370149536,WILD TYPE HIV-1 PROTEASE WITH POTENT ANTIVIRAL INHIBITOR GRL-0255A,PQITLWKRPLVTIKIGGQLKEALLDTGADDTVIEEMSLPGRWKPKMIGGIGGFIKVRQYDQIIIEIAGHKAIGTVLVGPTPVNIIGRNLLTQIGATLNF,0.9934363223614384,C4003DJK,5.255197808676359,0.9934363223614384,5.312619495139481,0.9704908085604348,5.274332757531797
63,1v2r,1.7,2004,3.55,Ki=278.96uM,0.5208107528242679,1747,30,14.835014976894067,TRYPSIN INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN VARIANT X(SSRI)BT.B4,IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSRIITSNMFCAGYLEGGKDSCQGDSGGPVVCSGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN,0.9970428824636558,C4001V2R,19.7260019924969,0.9970428824636558,14.07119012933646,0.9760179470358002,14.2265305743999
64,1g74,1.7,2003,6.52,Kd=0.30uM,0.8449829546235583,1155,20,6.147754389049704,"TOWARD CHANGING SPECIFICITY: ADIPOCYTE LIPID BINDING PROTEIN MUTANT, 2 OLEIC ACID BOUND FORM",CDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDLVTIRSESTFKNTEISFKLGVEFDEETVDGRKVKSIITLDGGALVQVQKWDGKSTTIKRKRDGDKLVVECVMKGVTSTRVYERA,0.9916504550255784,C4001G74,5.5296738929982485,0.9916504550255784,5.756017707168491,0.9542737854693467,4.718462479533745
65,2f35,1.87,2006,5.4,Kd=3.94uM,0.7368504993453868,2235,24,4.8589452240560735,CRYSTAL STRUCTURE OF THE GLUR5 LIGAND BINDING CORE WITH UBP302 AT 1.87 2 ANGSTROMS RESOLUTION,GSNRTLIVTTILEEPYVMYRKSDKPLYGNDRFEGYCLDLLKELSNILGFLYDVKLVPDGKYGAQNDKGEWNGMVKELIDHRADLAVAPLTITYVREKVIDFSKPFMTLGISILYRKGTPIDSADDLAKQTKIEYGAVRDGSTMTFFKKSKISTYEKMWAFMSSRQQSALVKNSDEGIQRVLTTDYALLMESTSIEYVTQRNCNLTQIGGLIDSKGYGVGTPIGSPYRDKITIAILQLQEEGKLHMMKEKWWRGNGCPS,0.9920670332862084,C4002F35,5.027647869760662,0.9920670332862084,4.5915568368964434,0.9622037597273516,4.154173693409815
66,3bgz,2.4,2007,6.26,Ki=0.55uM,0.7783807205811852,2326,24,11.144878340166764,HUMAN PIM-1 KINASE IN COMPLEX WITH DIPHENYL INDOLE 2 INHIBITOR VX3,MGSSHHHHHHSSGLVPRGSHMLLSKINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK,0.9928479328062162,C4003BGZ,28.93179205607649,0.9928479328062162,47.40339018993493,0.0,999.0
67,2ogy,2.3,2007,4.48,Kd=33.2uM,0.6510097516273059,4345,33,21.2330475705231,ASN199ALA MUTANT OF THE 5-METHYLTETRAHYDROFOLATE CORRINOID/IRON SULFUR 2 PROTEIN METHYLTRANSFERASE COMPLEXED WITH METHYLTETRAHYDROFOLATE TO 3 2.3 ANGSTROM RESOLUTION,MLIIGERINGMFGDIKRAIQERDPAPVQEWARRQEEGGARALDLNVGPAVQDKVSAMEWLVEVTQEVSNLTLCLDSTNIKAIEAGLKKCKNRAMINSTNAEREKVEKLFPLAVEHGAALIGLTMNKTGIPKDSDTRLAFAMELVAAADEFGLPMEDLYIDPLILPANVAQDHAPEVLKTLQQIKMLADPAPKTVLGLSAVSQNCQNRPLINRTFLAMAMACGLDAAIADACDEALIETAATAEILLNQTVYCDSFVKMFKTR,0.9942235552632288,C4002OGY,22.36204949505622,0.9942235552632288,21.77013747731323,0.9854081282331058,22.16876038505194
68,2v00,1.55,2007,3.66,Kd=0.22mM,0.7858785532742243,2994,16,7.3416202826781,X-RAY CRYSTAL STRUCTURE OF ENDOTHIAPEPSIN COMPLEXED WITH 2 COMPOUND 1,STGSATTTPIDSLDDAYITPVQIGTPAQTLNLDFDTGSSDLWVFSSETTASEVDGQTIYTPSKSTTAKLLSGATWSISYGDGSSSSGDVYTDTVSVGGLTVTGQAVESAKKVSSSFTEDSTIDGLLGLAFSTLNTVSPTQQKTFFDNAKASLDSPVFTADLGYHAPGTYNFGFIDTTAYTGSITYTAVSTKQGFWEWTSTGYAVGSGTFKSTSIDGIADTGTTLLYLPATVVSAYWAQVSGAKSSSSVGGYVFPCSATLPSFTFGVGSARIVIPGDYIDFGPISTGSSSCFGGIQSSAGIGINIFGDVALKAAFVVFNGATTPTLGFASK,0.9565206544272844,C4002V00,7.794938086548636,0.9565206544272844,12.75283378002952,0.9435652681535072,8.16463241422113
69,1h1s,2.0,2002,8.22,Ki=6nM,0.7728274259239347,4952,28,23.63119398758913,STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED 2 WITH THE INHIBITOR NU6102,GPLGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL,0.5866922291221172,C4001H1S,16.623973039891197,0.5866922291221172,129.93593373137756,0.0,999.0
70,1zgi,2.2,2005,5.34,Ki=4.6uM,0.8282959583097529,2331,32,14.58781450857226,THROMBIN IN COMPLEX WITH AN OXAZOLOPYRIDINE INHIBITOR 21,DCGLRPLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG,0.6041359586216096,C4001ZGI,34.92584493351939,0.6041359586216096,35.01466202837616,0.0,999.0
71,1kdk,1.7,2002,9.05,Kd=0.9nM,1.0246935981660443,2953,21,15.34421979322302,THE STRUCTURE OF THE N-TERMINAL LG DOMAIN OF SHBG IN 2 CRYSTALS SOAKED WITH EDTA,DPPAVHLSNGPGQEPIAVMTFDLTKITKTSSSFEVRTWDPEGVIFYGDTNPKDDWFMLGLRDGRPEIQLHNHWAQLTVGAGPRLDDGRWHQVEVKMEGDSVLLEVDGEEVLRLRQVSGPLTSKRHPIMRIALGGLLFPASNLRLPLVPALDGCLRRDSWLDKQAEISASAPTSLRSC,0.9939824047961284,C4001KDK,15.089192592510742,0.9939824047961284,15.248305270652722,0.9827841016643849,15.188114058196312
72,1e1x,1.85,2001,5.89,Ki=1.3uM,0.8787654483997043,2499,18,12.8663686980859,HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR NU6027,XMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL,0.8696009317719838,C4001E1X,29.78608812703735,0.8696009317719838,29.156123251504766,0.0,999.0
73,2o4r,1.98,2007,9.4,Ki=0.4nM,0.9765228466645188,2109,30,8.87288638089882,CRYSTAL STRUCTURE OF RAT VITAMIN D RECEPTOR LIGAND BINDING DOMAIN 2 COMPLEXED WITH VITIII 17-20E AND THE NR2 BOX OF DRIP 205,LKDSLRPKLSEEQQHIIAILLDAHHKTYDPTYADFRDFRPPVRMDGSTGSVTLDLSPLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSDDQIVLLKSSAIEVIMLRSNQSFTMDDMSWDCGSQDYKYDVTDVSKAGHTLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAKLVEAIQDRLSNTLQTYIRCRHPPPGSHQLYAKMIQKLADLRSLNEEHSKQYRSLSFQPENSMKLTPLVLEVFGNEISLVPRGSMAISDPNSSSVDKLAAALEHHHHHH,0.7273878560501921,C4002O4R,28.08050061122353,0.7273878560501921,33.101045590233895,0.0,999.0
74,1nvq,2.0,2003,8.25,Ki=5.6nM,0.8152838123255639,2368,36,11.609613047413584,THE COMPLEX STRUCTURE OF CHECKPOINT KINASE CHK1/UCN-01,MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSG,0.8741823768958357,C4001NVQ,26.349799365879328,0.8741823768958357,204.07675424195736,0.0,999.0
75,1c5x,1.75,2000,6.68,Ki=0.21uM,0.8769761684463228,2316,13,12.316318414843028,"STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB- 2 MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR",KPSSPPEELKFQCGQKTLRPRFK,0.9955657683198736,C4001C5X,12.676101702392716,0.9955657683198736,12.585534000918996,0.0,999.0
76,1w3k,1.2,2004,4.3,Ki=50uM,0.8177733445633892,2858,21,13.133241809760143,ENDOGLUCANASE CEL5A FROM BACILLUS AGARADHAERENS IN COMPLEX WITH 2 CELLOBIO DERIVED-TETRAHYDROOXAZINE,DNDSVVEEHGQLSISNGELVNERGEQVQLKGMSSHGLQWYGQFVNYESMKWLRDDWGINVFRAAMYTSSGGYIDDPSVKEKVKEAVEAAIDLDIYVIIDWHILSDNDPNIYKEEAKDFFDEMSELYGDYPNVIYEIANEPNGSDVTWGNQIKPYAEEVIPIIRNNDPNNIIIVGTGTWSQDVHHAADNQLADPNVMYAFHFYAGTHGQNLRDQVDYALDQGAAIFVSEWGTSAATGDGGVFLDEAQVWIDFMDERNLSWANWSLTHKDESSAALMPGANPTGGWTEAELSPSGTFVREKIRES,0.9956143983433934,C4001W3K,13.09800175971528,0.9956143983433934,13.17498642366438,0.0,999.0
77,1n4h,2.1,2003,6.55,Ki=0.28uM,0.8822133381992712,2111,22,7.119181769600778,CHARACTERIZATION OF LIGANDS FOR THE ORPHAN NUCLEAR RECEPTOR 2 RORBETA,GQLAPGITMSEIDRIAQNIIKSHLETCQYTMEELHQLAWQTHTYEEIKAYQSKSREALWQQCAIQITHAIQYVVEFAKRITGFMELCQNDQILLLKSGCLEVVLVRMCRAFNPLNNTVLFEGKYGGMQMFKALGSDDLVNEAFDFAKNLCSLQLTEEEIALFSSAVLISPDRAWLLEPRKVQKLQEKIYFALQHVIQKNHLDDETLAKLIAKIPTITAVCNLHGEKLQVFKQSHPDIVNTLFPPLYKELFNPDCAAVCK,0.995681455163286,C4001N4H,7.180180823260751,0.995681455163286,6.983913334287909,0.9757251013486015,6.852966225548783
78,2e2r,1.6,2007,8.26,Kd=5.5nM,1.0709277719147634,4402,17,17.513991143586374,CRYSTAL STRUCTURE OF HUMAN ESTROGEN-RELATED RECEPTOR GAMMA LIGAND 2 BINDING DOMAIN COMPLEX WITH BISPHENOL A,LGSPEFLNPQLVQPAKKPYNKIVSHLLVAEPEKIYAMPDPTVPDSDIKALTTLCDLADRELVVIIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDELVYADDYIMDEDQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANSDSMHIEDVEAVQKLQDVLHEALQDYEAGQHMEDPRRAGKMLMTLPLLRQTSTKAVQHFYNIKLEGKVPMHKLFLEMLEAKVC,0.9903181317622632,C4002E2R,17.161532665127694,0.9903181317622632,17.069007362245472,0.9711862033432285,17.283019696926182
79,1lf2,1.8,2002,7.52,Ki=30nM,0.7812830637914904,2981,39,8.186309479126413,CRYSTAL STRUCTURE OF PLASMEPSIN II FROM P FALCIPARUM IN COMPLEX WITH 2 INHIBITOR RS370,LGSSNDNIELVDFQNIMFYGDAEVGDNQQPFTFILDTGSANLWVPSVKCTTAGCLTKHLYDSSKSRTYEKDGTKVEMNYVSGTVSGFFSKDLVTVGNLSLPYKFIEVIDTNGFEPTYTASTFDGILGLGWKDLSIGSVDPIVVELKNQNKIENALFTFYLPVHDKHTGFLTIGGIEERFYEGPLTYEKLNHDLYWQITLDAHVGNISLEKANCIVDSGTSAITVPTDFLNKMLQNLDVIKVPFLPFYVTLCNNSKLPTFEFTSENGKYTLEPEYYLQHIEDVGPGLCMLNIIGLDFPVPTFILGDPFMRKYFTVFDYDNHSVGIALAKKNL,0.9815385038654764,C4001LF2,8.238502021676574,0.9815385038654764,8.731946853632763,0.9389802889154585,9.620373574954783
80,5std,1.95,1999,10.49,Ki=32pM,1.0237183666860672,4374,28,17.151004280319835,SCYTALONE DEHYDRATASE PLUS INHIBITOR 2,GEITFSDYLGLMTCVYEWADSYDSKDWDRLRKVIAPTLRIDYRSFLDKLWEAMPAEEFVGMVSSKQVLGDPTLRTQHFIGGTRWEKVSEDEVIGYHQLRVPHQRYKDTTMKEVTMKGHAHSANLHWYKKIDGVWKFAGLKPDIRWGEFDFDRIFEDGRETFGDK,0.994330844738413,C4005STD,17.643488356224463,0.994330844738413,17.368123977876014,0.985793544475191,18.335927001268534
81,1v0k,1.03,2004,5.1,Ki=8uM,0.8355816187769228,3049,18,9.774988234460574,XYLANASE XYN10A FROM STREPTOMYCES LIVIDANS IN COMPLEX WITH XYLOBIO- 2 DEOXYNOJIRIMYCIN AT PH 5.8,AESTLGAAAAQSGRYFGTAIASGRLSDSTYTSIAGREFNMVTAENEMKIDATEPQRGQFNFSSADRVYNWAVQNGKQVRGHTLAWHSQQPGWMQSLSGSALRQAMIDHINGVMAHYKGKIVQWDVVNEAFADGSSGARRDSNLQRSGNDWIEVAFRTARAADPSAKLCYNDYNVENWTWAKTQAMYNMVRDFKQRGVPIDCVGFQSHFNSGSPYNSNFRTTLQNFAALGVDVAITELDIQGAPASTYANVTNDCLAVSRCLGITVWGVRDSDSWRSEQTPLLFNNDGSKKAAYTAVLDALNGGDSSEPPADGG,0.9928397132012629,C4001V0K,9.710859908757907,0.9928397132012629,8.120454966043084,0.9801768240883084,9.388281275879073
82,1m48,1.95,2002,5.09,Kd=8.2uM,0.6052224826814603,1142,33,16.6290481595513,CRYSTAL STRUCTURE OF HUMAN IL-2 COMPLEXED WITH (R)-N-[2-[1- 2 (AMINOIMINOMETHYL)-3-PIPERIDINYL]-1-OXOETHYL]-4-(PHENYLETHYNYL)-L- 3 PHENYLALANINE METHYL ESTER,APTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT,0.9623241898456528,C4001M48,20.65578324665332,0.9623241898456528,27.497391213624034,0.0,999.0
83,1fh7,1.82,2000,5.24,Ki=5.8uM,0.848931493640012,2686,18,8.939191859214757,CRYSTAL STRUCTURE OF THE XYLANASE CEX WITH XYLOBIOSE-DERIVED INHIBITOR 2 DEOXYNOJIRIMYCIN,ATTLKEAADGAGRDFGFALDPNRLSEAQYKAIADSEFNLVVAENAMKWDATEPSQNSFSFGAGDRVASYAADTGKELYGHTLVWHSQLPDWAKNLNGSAFESAMVNHVTKVADHFEGKVASWDVVNEAFADGGGRRQDSAFQQKLGNGYIETAFRAARAADPTAKLCINDYNVEGINAKSNSLYDLVKDFKARGVPLDCVGFQSHLIVGQVPGDFRQNLQRFADLGVDVRITELDIRMRTPSDATKLATQAADYKKVVQACMQVTRCQGVTVWGITDKYSWVPDVFPGEGAALVWDASYAKKPAYAAVMEAF,0.995548132659784,C4001FH7,8.992120751663759,0.995548132659784,9.25332659337767,0.0,999.0
84,1n46,2.2,2003,10.52,Ki=0.03nM,1.0822007396783413,4013,27,21.800927313603136,CRYSTAL STRUCTURE OF HUMAN TR BETA LIGAND-BINDING DOMAIN COMPLEXED 2 WITH A POTENT SUBTYPE-SELECTIVE THYROMIMETIC,LQKSIGHKPEPTDEEWELIKTVTEAHVATNAQGSHWKQKRKFLPEDIGQAPIVNAPEGGKVDLEAFSHFTKIITPAITRVVDFAKKLPMFCELPCEDQIILLKGCCMEIMSLRAAVRYDPESETLTLNGEMAVTRGQLKNGGLGVVSDAIFDLGMSLSSFNLDDTEVALLQAVLLMSSDRPGLACVERIEKYQDSFLLAFEHYINYRKHHVTHFWPKLLMKVTDLRMIGACHASRFLHMKVECPTELFPPLFLEVFED,0.9904540069685924,C4001N46,22.20504762047382,0.9904540069685924,33.29397663268585,0.0,999.0
85,1v0l,0.98,2004,7.55,Ki=0.028uM,0.8295329581282965,2989,17,10.006162704292976,XYLANASE XYN10A FROM STREPTOMYCES LIVIDANS IN COMPLEX WITH XYLOBIO- 2 ISOFAGOMINE AT PH 5.8,AESTLGAAAAQSGRYFGTAIASGRLSDSTYTSIAGREFNMVTAENEMKIDATEPQRGQFNFSSADRVYNWAVQNGKQVRGHTLAWHSQQPGWMQSLSGSALRQAMIDHINGVMAHYKGKIVQWDVVNEAFADGSSGARRDSNLQRSGNDWIEVAFRTARAADPSAKLCYNDYNVENWTWAKTQAMYNMVRDFKQRGVPIDCVGFQSHFNSGSPYNSNFRTTLQNFAALGVDVAITELDIQGAPASTYANVTNDCLAVSRCLGITVWGVRDSDSWRSEQTPLLFNNDGSKKAAYTAVLDALNGGDSSEPPADGG,0.9949270489507104,C4001V0L,9.87704070028828,0.9949270489507104,8.202424636855666,0.9838039092734789,10.35439281766485
86,2j34,2.01,2006,7.82,Ki=15nM,0.7753677055386475,2462,30,16.664702681341907,CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX,IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK,0.789481305892513,C4002J34,16.492772319001446,0.789481305892513,16.4241310206896,0.9815106478347124,16.73423205062619
87,1mfi,1.8,1999,5.59,Ki=2.6uM,1.0351618926939878,2713,13,15.289282929738157,CRYSTAL STRUCTURE OF MACROPHAGE MIGRATION INHIBITORY FACTOR COMPLEXED 2 WITH (E)-2-FLUORO-P-HYDROXYCINNAMATE,PMFIVNTNVPRASVPEGFLSELTQQLAQATGKPAQYIAVHVVPDQLMTFSGTNDPCALCSLHSIGKIGGAQNRNYSKLLCGLLSDRLHISPDRVYINYYDMNAANVGWNGSTFA,0.994205841400586,C4001MFI,15.455160367495854,0.994205841400586,14.923532122998315,0.9890191696994268,15.855339318123328
88,2gst,1.8,1993,6.07,Ki=0.85uM,0.8028139976303178,4141,35,12.44334538267453,"STRUCTURE OF THE XENOBIOTIC SUBSTRATE BINDING SITE OF A GLUTATHIONE S- 2 TRANSFERASE AS REVEALED BY X-RAY CRYSTALLOGRAPHIC ANALYSIS OF PRODUC 3 COMPLEXES WITH THE DIASTEREOMERS OF 9-(S-GLUTATHIONYL)-10-HYDROXY-9, 4 10-DIHYDROPHENANTHRENE",PMILGYWNVRGLTHPIRLLLEYTDSSYEEKRYAMGDAPDYDRSQWLNEKFKLGLDFPNLPYLIDGSRKITQSNAIMRYLARKHHLCGETEEERIRADIVENQVMDNRMQLIMLCYNPDFEKQKPEFLKTIPEKMKLYSEFLGKRPWFAGDKVTYVDFLAYDILDQYHIFEPKCLDAFPNLKDFLARFEGLKKISAYMKSSRYLSTPIFSKLAQWSNK,0.996391014337182,C4002GST,12.245570236301772,0.996391014337182,11.781658491043297,0.9717306805648315,11.583446817449618
89,2fqw,1.71,2006,6.68,Kd=210nM,0.9872956662815564,2592,19,5.563682947272199,PNRA FROM TREPONEMA PALLIDUM AS PURIFIED FROM E. COLI 2 (BOUND TO INOSINE),EGGDFVVGMVTDSGDIDDKSFNQQVWEGISRFAQENNAKCKYVTASTDAEYVPSLSAFADENMGLVVACGSFLVEAVIETSARFPKQKFLVIDAVVQDRDNVVSAVFGQNEGSFLVGVAAALKAKEAGKSAVGFIVGMELGMMPLFEAGFEAGVKAVDPDIQVVVEVANTFSDPQKGQALAAKLYDSGVNVIFQVAGGTGNGVIKEARDRRLNGQDVWVIGVDRDQYMDGVYDGSKSVVLTSMVKRADVAAERISKMAYDGSFPGGQSIMFGLEDKAVGIPEENPNLSSAVMEKIRSFEEKIVSKEIVVPVRSARMMN,0.993050309132156,C4002FQW,5.285589260135857,0.993050309132156,5.651088438656659,0.0,999.0
90,1mu6,1.99,2004,8.38,Ki=4.2nM,0.8671521098733881,2370,31,14.59137514197185,"CRYSTAL STRUCTURE OF THROMBIN IN COMPLEX WITH L-378,622",TFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGR,0.6533353124755011,C4001MU6,881.4033153574744,0.6533353124755011,390.13533916060896,0.0,999.0
91,2f34,1.74,2006,6.89,Kd=0.13uM,0.7861045210011026,2269,24,4.889541979967209,CRYSTAL STRUCTURE OF THE GLUR5 LIGAND BINDING CORE DIMER WITH UBP310 2 AT 1.74 ANGSTROMS RESOLUTION,GSNRTLIVTTILEEPYVMYRKSDKPLYGNDRFEGYCLDLLKELSNILGFLYDVKLVPDGKYGAQNDKGEWNGMVKELIDHRADLAVAPLTITYVREKVIDFSKPFMTLGISILYRKGTPIDSADDLAKQTKIEYGAVRDGSTMTFFKKSKISTYEKMWAFMSSRQQSALVKNSDEGIQRVLTTDYALLMESTSIEYVTQRNCNLTQIGGLIDSKGYGVGTPIGSPYRDKITIAILQLQEEGKLHMMKEKWWRGNGCPS,0.9937991603573164,C4002F34,5.080660793049948,0.9937991603573164,4.907093295427528,0.974216497695675,4.803372530805615
92,2qm9,2.31,2007,7.77,Kd=17nM,0.9009753492597412,2215,31,12.906755990882992,TROGLITAZONE BOUND TO FATTY ACID BINDING PROTEIN 4,GSHMASMTGGNNMGRGSSSKVYKMCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDLVTIRSESTFKNTEISFKLGVEFDEITADDRKVKSIITLDGGALVQVQKWDGKSTTIKRKRDGDKLVVECVMKGVTSTRVYERA,0.9918359405675756,C4002QM9,13.073609128726853,0.9918359405675756,13.999930470165648,0.9657585256147637,12.982663504864382
93,2cgf,2.2,2006,6.41,Kd=0.39uM,0.831431766556002,3778,23,20.60357340788389,A RADICICOL ANALOGUE BOUND TO THE ATP BINDING SITE OF THE N- 2 TERMINAL DOMAIN OF THE YEAST HSP90 CHAPERONE,MRGSHHHHHHGMASETFEFQAEITQLMSLIINTVYSNKEIFLRELISNASDALDKIRYKSLSDPKQLETEPDLFIRITPKPEQKVLEIRDSGIGMTKAELINNLGTIAKSGTKAFMEALSAGADVSMIGQFGVGFYSLFLVADRVQVISKSNDDEQYIWESNAGGSFTVTLDEVNERIGRGTILRLFLKDDQLEYLEEKRIKEVIKKHSEFVAYPIQLVVTKEVE,0.993064333894168,C4002CGF,21.592474428823184,0.993064333894168,20.74687659824155,0.9797547611819506,21.564102202718008
94,2hb1,2.0,2006,3.8,Ki=160uM,0.9421710315468668,2611,14,12.7179725277871,CRYSTAL STRUCTURE OF PTP1B WITH MONOCYCLIC THIOPHENE INHIBITOR,MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDL,0.9944876766971738,C4002HB1,12.790469915365252,0.9944876766971738,11.978185988042243,0.9757729554370095,12.248412715232678
95,2iwx,1.5,2006,6.68,Kd=0.21uM,0.8098364974746167,2124,24,6.975814950572743,ANALOGUES OF RADICICOL BOUND TO THE ATP-BINDING SITE OF 2 HSP90.,MASETFEFQAEITQLMSLIINTVYSNKEIFLRELISNASDALDKIRYKSLSDPKQLETEPDLFIRITPKPEQKVLEIRDSGIGMTKAELINNLGTIAKSGTKAFMEALSAGADVSMIGQFGVGFYSLFLVADRVQVISKSNDDEQYIWESNAGGSFTVTLDEVNERIGRGTILRLFLKDDQLEYLEEKRIKEVIKRHSEFVAYPIQLVVTKEVE,0.987838352970503,C4002IWX,7.268429813382942,0.987838352970503,7.348081020447967,0.9639683528229005,6.487585328966298
96,1q8t,2.0,2003,4.76,Kd=17.5uM,0.8257076955336549,3218,18,9.328285388711612,THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE 2 (PKA) IN COMPLEX WITH RHO-KINASE INHIBITOR Y-27632,GNAAAAKKGXEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIRVXINEKCGKEFSEF,0.994910177381433,C4001Q8T,9.658847259588557,0.994910177381433,9.159350961934646,0.0,999.0
97,2zb1,2.5,2008,6.32,Kd=0.48uM,0.9771116263663464,3065,26,9.947728697035656,CRYSTAL STRUCTURE OF P38 IN COMPLEX WITH BIPHENYL AMIDE INHIBITOR,MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES,0.9921433989241866,C4002ZB1,564.8131391490205,0.9921433989241866,9.90956758218736,0.9743887100179409,10.312825323651513
98,3eko,1.55,2008,6.7,Ki=0.2uM,0.8360356706117065,1903,16,6.598916304545638,DIHYDROXYLPHENYL AMIDES AS INHIBITORS OF THE HSP90 2 MOLECULAR CHAPERONE,MDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKELEHHHHHH,0.9631771028043984,C4003EKO,6.877003918748302,0.9631771028043984,5.842648355716426,0.9408685662928672,7.420572822718637
99,1adl,1.6,1994,5.36,Kd=4.4uM,0.7351629493671106,2236,22,14.642828669303595,ADIPOCYTE LIPID BINDING PROTEIN COMPLEXED WITH ARACHIDONIC ACID: X-RAY 2 CRYSTALLOGRAPHIC AND TITRATION CALORIMETRY STUDIES,CDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDLVTIRSESTFKNTEISFKLGVEFDEITADDRKVKSIITLDGGALVQVQKWDGKSTTIKRKRDGDKLVVECVMKGVTSTRVYERA,0.9918547875457596,C4001ADL,14.373392601068709,0.9918547875457596,14.583786922178708,0.9346962774647356,15.585228430315514
100,1d6v,2.0,2000,6.17,Kd=670nM,0.6435332225710904,3486,28,28.564070876101347,CONFORMATION EFFECTS IN BIOLOGICAL CATALYSIS INTRODUCED BY OXY-COPE 2 ANTIBODY MATURATION,DIKMTQSPSSMYASLGERVTITCKASQDINSYLSWFQQKPGKSPKTLIYRANRLVDGVPSRFSGSGSGQDYSLTISSLEYEDMGIYYCLQYDEFPYTFGSGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNR,0.9965033214459538,C4001D6V,28.69157036464916,0.9965033214459538,28.56462997890681,0.9649806933688602,29.193873174566832
101,1fcz,1.38,2000,9.22,Kd=0.6nM,1.01374477386803,2183,27,8.37146916852971,ISOTYPE SELECTIVITY OF THE HUMAN RETINOIC ACID NUCLEAR RECEPTOR HRAR: 2 THE COMPLEX WITH THE PANAGONIST RETINOID BMS181156,SPQLEELITKVSKAHQETFPSLCQLGKYTTNSSADHRVQLDLGLWDKFSELATKCIIKIVEFAKRLPGFTGLSIADQITLLKAACLDILMLRICTRYTPEQDTMTFSDGLTLNRTQMHNAGFGPLTDLVFAFAGQLLPLEMDDTETGLLSAICLICGDRMDLEEPEKVDKLQEPLLEALRLYARRRRPSQPYMFPRMLMKITDLRGISTKGAERAITLKMEIPGPMPPLIREMLE,0.9919291697889092,C4001FCZ,8.775876223217518,0.9919291697889092,8.628485366141925,0.9666680407820395,8.626672992794928
102,1fl3,2.45,2000,6.8,Kd=0.16uM,0.8961054607604158,3313,23,22.372930450066583,CRYSTAL STRUCTURE OF THE BLUE FLUORESCENT ANTIBODY (19G2) IN COMPLEX 2 WITH STILBENE HAPTEN AT 277K,AALLESGGGLVKPGGSLKLSCTASGITFSRYIMSWVRQIPEKRLEWVASISSGGITYYPDSVAGRFTISRDNVRNILYLQMSSLRSEDTALYYCARGQGRPYWGQGTSVTVSAAKTTPPSVYPAAPGCGDTTGSSVTLGCLVKGYFPEPVTVTWNSGGSSVHTFPALLQSGLYTMSSSVTVPSSTWPSTVTCSVAHPASSTTVDKKLE,0.9952229708901014,C4001FL3,21.92484441711722,0.9952229708901014,22.142916457289807,0.9669112091449178,23.342503739964236
103,2qbq,2.1,2008,7.44,Ki=0.036uM,0.7409437318970207,2727,31,14.105663981721255,CRYSTAL STRUCTURE OF PTP1B-INHIBITOR COMPLEX,MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDL,0.9949334659954184,C4002QBQ,14.108305533340626,0.9949334659954184,15.32656494235878,0.9774148008137031,15.300795353564649
104,2fqx,1.7,2006,7.15,Kd=71nM,0.9555915866833588,2628,20,5.763731485816646,PNRA FROM TREPONEMA PALLIDUM COMPLEXED WITH GUANOSINE,EGGDFVVGMVTDSGDIDDKSFNQQVWEGISRFAQENNAKCKYVTASTDAEYVPSLSAFADENMGLVVACGSFLVEAVIETSARFPKQKFLVIDAVVQDRDNVVSAVFGQNEGSFLVGVAAALKAKEAGKSAVGFIVGMELGMMPLFEAGFEAGVKAVDPDIQVVVEVANTFSDPQKGQALAAKLYDSGVNVIFQVAGGTGNGVIKEARDRRLNGQDVWVIGVDRDQYMDGVYDGSKSVVLTSMVKRADVAAERISKMAYDGSFPGGQSIMFGLEDKAVGIPEENPNLSSAVMEKIRSFEEKIVSKEIVVPVRSARMMN,0.9914915350228358,C4002FQX,5.6451020515270365,0.9914915350228358,5.712600375276047,0.0,999.0
105,1xhy,1.85,2005,6.18,Ki=662nM,0.9638164936938614,4775,15,16.379989620507143,X-RAY STRUCTURE OF THE Y702F MUTANT OF THE GLUR2 LIGAND-BINDING CORE 2 (S1S2J) IN COMPLEX WITH KAINATE AT 1.85 A RESOLUTION,GANKTVVVTTILESPYVMMKKNHEMLEGNERYEGYCVDLAAEIAKHCGFKYKLTIVGDGKYGARDADTKIWNGMVGELVYGKADIAIAPLTITLVREEVIDFSKPFMSLGISIMIKKGTPIESAEDLSKQTEIAYGTLDSGSTKEFFRRSKIAVFDKMWTYMRSAEPSVFVRTTAEGVARVRKSKGKYAFLLESTMNEYIEQRKPCDTMKVGGNLDSKGYGIATPKGSSLGNAVNLAVLKLNEQGLLDKLKNKWWYDKGECGS,0.9945608371824014,C4001XHY,16.463769474043563,0.9945608371824014,15.700798988698226,0.9780818206580432,15.670476884264666
106,1jqy,2.14,2002,4.92,Ki=12uM,0.6838707100918523,4620,33,27.61345946177745,HEAT-LABILE ENTEROTOXIN B-PENTAMER WITH LIGAND BMSC-0010,APQTITELCSEYRNTQIYTINDKILSYTESMAGKREMVIITFKSGETFQVEVPGSQHIDSQKKAIERMKDTLRITYLTETKIDKLCVWNNKTPNSIAAISMKN,0.9972780103256202,C4001JQY,27.88550575372776,0.9972780103256202,28.39950689056957,0.9828416629246158,27.519650414719347
107,1f4x,2.3,2000,5.59,Kd=2.6uM,0.7711380042560746,3231,20,29.91315622431001,CRYSTAL STRUCTURE OF AN ANTI-CARBOHYDRATE ANTIBODY DIRECTED AGAINST 2 VIBRIO CHOLERAE O1 IN COMPLEX WITH ANTIGEN,QAVVTQESALTTSPGETVTLTCRSSTGTVTTSNYANWVQEKPDHLFTGLIGATNNRAAGVPVRFSGSLIGGKAALTITGAQTEDEAIYFCALWYSGHWVFGGGTKLTVLGQPKSSPSVTLFPPSSEELETNKATLVCTITDFYPGVVTVDWKVDGTPVTQGMETTNPSKQSNNKYMASSYLTLTARAWERHSSYSCQVTHEGHTVEKSLS,0.996163698412204,C4001F4X,30.66811499415832,0.996163698412204,29.93281716559026,0.9785070678192515,30.013626986829323
108,1no6,2.4,2003,4.41,Ki=39uM,0.7233760857908847,2584,25,12.1221137336302,"POTENT, SELECTIVE PROTEIN TYROSINE PHOSPHATASE 1B INHIBITOR COMPOUND 5 2 USING A LINKED-FRAGMENT STRATEGY",MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN,0.9885054640944836,C4001NO6,12.513841274130112,0.9885054640944836,12.096520389714712,0.9758099190823207,12.253934546882927
109,1enu,1.95,2000,5.08,Ki=8.3uM,0.915462034588383,3372,13,9.050827532683815,A NEW TARGET FOR SHIGELLOSIS: RATIONAL DESIGN AND CRYSTALLOGRAPHIC 2 STUDIES OF INHIBITORS OF TRNA-GUANINE TRANSGLYCOSYLASE,MVEATAQETDRPRFSFSIAAREGKARTGTIEMKRGVIRTPAFMPVGTAATVKALKPETVRATGADIILGNTYHLMLRPGAERIAKLGGLHSFMGWDRPILTDSGGYQVMSLSSLTKQSEEGVTFKSHLDGSRHMLSPERSIEIQHLLGSDIVMAFDECTPYPATPSRAASSMERSMRWAKRSRDAFDSRKEQAENAALFGIQQGSVFENLRQQSADALAEIGFDGYAVGGLAVGEGQDEMFRVLDFSVPMLPDDKPHYLMGVGKPDDIVGAVERGIDMFDCVLPTRSGRNGQAFTWDGPINIRNARFSEDLKPLDSECHCAVCQKWSRAYIHHLIRAGEILGAMLMTEHNIAFYQQLMQKIRDSISEGRFSQFAQDFRARYFARNS,0.996533557149224,C4001ENU,9.31294027254602,0.996533557149224,9.409088525681826,0.9742492121880083,44.392530856054655
110,2gss,1.9,1997,4.94,Ki=11.5uM,0.5914987345834336,3608,19,17.726022247754145,HUMAN GLUTATHIONE S-TRANSFERASE P1-1 IN COMPLEX WITH 2 ETHACRYNIC ACID,PPYTVVYFPVRGRCAALRMLLADQGQSWKEEVVTVETWQEGSLKASCLYGQLPKFQDGDLTLYQSNTILRHLGRTLGLYGKDQQEAALVDMVNDGVEDLRCKYISLIYTNYEAGKDDYVKALPGQLKPFETLLSQNQGGKTFIVGDQISFADYNLLDLLLIHEVLAPGCLDAFPLLSAYVGRLSARPKLKAFLASPEYVNLPINGNGKQ,0.9959315406782157,C4002GSS,19.921714915275647,0.9959315406782157,19.18980279890475,0.9697296160291865,17.31927153719426
111,2qbu,2.1,2008,6.19,Kd=0.645uM,1.0426207232068714,3952,26,11.27844106671522,CRYSTAL STRUCTURE OF METHANOTHERMOBACTER THERMAUTOTROPHICUS CBIL,MHGKLIGVGVGPGDSELLTLRAVNVLRSVPVICAPRSSSERESIALSIVEDILTERRDGCRILDPVFPMTDDRDELESHWDSAARMVAAELEDGRDVAFITLGDPSIYSTFSYLQQRIEDMGFKTEMVPGVTSFTACAATAGRTLVEGDEILLVVPRVDDRFERVLRDVDACVIMKTSRHGRRAMEVVESDPRGKDVVSVANCSMDDEVVERGFASGGGYLATTLVRFREQS,0.996387609796441,C4002QBU,11.442978475471133,0.996387609796441,10.964084757239569,0.975904013141224,11.616399949938227
112,1td7,2.5,2004,4.37,Kd=43uM,0.7349335907397679,1036,20,7.656244371894802,INTERACTIONS OF A SPECIFIC NON-STEROIDAL ANTI-INFLAMMATORY 2 DRUG (NSAID) WITH GROUP I PHOSPHOLIPASE A2 (PLA2): CRYSTAL 3 STRUCTURE OF THE COMPLEX FORMED BETWEEN PLA2 AND NIFLUMIC 4 ACID AT 2.5 A RESOLUTION,NLYQFKNMIQCTVPSRSWQDFADYGCYCGKGGSGTPVDDLDRCCQVHDNCYNEAENISGCRPYFKTYSYECTQGTLTCKGDNNACAASVCDCDRLAAICFAGAPYNDANYNIDLKARCN,0.9827103695621494,C4001TD7,10.997225498231511,0.9827103695621494,10.7768811423073,0.9407501930677472,9.651663701152547
113,1oyq,1.9,2003,6.96,Ki=110nM,0.6130058791751913,1838,39,14.73891699594695,TRYPSIN INHIBITOR COMPLEX,IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVVCSGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN,0.9958757609648744,C4001OYQ,14.779530282094557,0.9958757609648744,14.51154981646004,0.9743129690194141,14.173781999558985
114,1p1o,1.6,2003,5.76,Kd=1.74uM,1.0783319866645844,4375,13,15.62939553822158,CRYSTAL STRUCTURE OF THE GLUR2 LIGAND-BINDING CORE (S1S2J) MUTANT 2 L650T IN COMPLEX WITH QUISQUALATE,GANKTVVVTTILESPYVMMKKNHEMLEGNERYEGYCVDLAAEIAKHCGFKYKLTIVGDGKYGARDADTKIWNGMVGELVYGKADIAIAPLTITLVREEVIDFSKPFMSLGISIMIKKGTPIESAEDLSKQTEIAYGTTDSGSTKEFFRRSKIAVFDKMWTYMRSAEPSVFVRTTAEGVARVRKSKGKYAYLLESTMNEYIEQRKPCDTMKVGGNLDSKGYGIATPKGSSLGNAVNLAVLKLNEQGLLDKLKNKWWYDKGECGS,0.9953640263224472,C4001P1O,15.514184437443612,0.9953640263224472,39.42269323001419,0.9855243595175766,14.982488116753265
115,1o5e,1.75,2004,5.74,Ki=1.8uM,0.8274286492745726,2924,26,19.67019611650347,DISSECTING AND DESIGNING INHIBITOR SELECTIVITY DETERMINANTS AT THE S1 2 SITE USING AN ARTIFICIAL ALA190 PROTEASE (ALA190 UPA),SDQEPLYPVQVSSADARLMVFDKTEGTWRLLCSSRSNARVAGLSCEEMGFLRALTHSELDVRTAGAAGTSGFFCVDEGRLPHTQRLLEVISVCDCPRGRFLAAICQDCGRRKLP,0.4651757485884355,C4001O5E,255.44079394978505,0.4651757485884355,1384.2356911629272,0.0,999.0
116,1k4h,1.8,2002,5.11,Ki=7.7uM,0.8415193913206477,3327,18,7.637269190654335,"CRYSTAL STRUCTURE OF TRNA-GUANINE TRANSGLYCOSYLASE (TGT) COMPLEXED 2 WITH 2,6-DIAMINO-8-PROPYLSULFANYLMETHYL-3H-QUINAZOLINE-4-ONE",MVEATAQETDRPRFSFSIAAREGKARTGTIEMKRGVIRTPAFMPVGTAATVKALKPETVRATGADIILGNTYHLMLRPGAERIAKLGGLHSFMGWDRPILTDSGGYQVMSLSSLTKQSEEGVTFKSHLDGSRHMLSPERSIEIQHLLGSDIVMAFDECTPYPATPSRAASSMERSMRWAKRSRDAFDSRKEQAENAALFGIQQGSVFENLRQQSADALAEIGFDGYAVGGLAVGEGQDEMFRVLDFSVPMLPDDKPHYLMGVGKPDDIVGAVERGIDMFDCVLPTRSGRNGQAFTWDGPINIRNARFSEDLKPLDSECHCAVCQKWSRAYIHHLIRAGEILGAMLMTEHNIAFYQQLMQKIRDSISEGRFSQFAQDFRARYFARNS,0.9962471371671404,C4001K4H,8.17573880400848,0.9962471371671404,8.58260081732058,0.9802013463449218,7.7768042387702625
117,1ejn,1.8,2000,5.62,Ki=2.4uM,0.8931172190784156,2138,25,10.041272126031032,UROKINASE PLASMINOGEN ACTIVATOR B-CHAIN INHIBITOR COMPLEX,IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTISLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKEENGLAL,0.996249681650178,C4001EJN,10.056730712068282,0.996249681650178,9.855235764523329,0.9795757606953367,10.232735926514206
118,2std,2.1,1999,9.85,Ki=0.14nM,0.9903588463287024,4571,20,18.13864944001378,SCYTALONE DEHYDRATASE COMPLEXED WITH TIGHT-BINDING INHIBITOR 2 CARPROPAMID,MGSQVQKSDEITFSDYLGLMTCVYEWADSYDSKDWDRLRKVIAPTLRIDYRSFLDKLWEAMPAEEFVGMVSSKQVLGDPTLRTQHFIGGTRWEKVSEDEVIGYHQLRVPHQRYKDTTMKEVTMKGHAHSANLHWYKKIDGVWKFAGLKPDIRWGEFDFDRIFEDGRETFGDK,0.995208464089903,C4002STD,18.357172629825733,0.995208464089903,17.08222372743635,0.9819701299956177,18.686160264051733
119,2c3l,2.35,2005,5.07,Ki=8.58uM,0.6881852781601749,2393,18,13.378954215256549,IDENTIFICATION OF A BURIED POCKET FOR POTENT AND SELECTIVE INHIBITION 2 OF CHK1: PREDICTION AND VERIFICATION,MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGHHHHHHHH,0.8449384555317616,C4002C3L,28.97557091709363,0.8449384555317616,28.28506375701497,0.0,999.0
120,1od8,1.05,2003,5.1,Ki=8uM,0.831342237148471,2971,18,9.802610624765324,XYLANASE XYN10A FROM STREPTOMYCES LIVIDANS IN COMPLEX WITH XYLOBIO- 2 ISOFAGOMINE LACTAM,AESTLGAAAAQSGRYFGTAIASGRLSDSTYTSIAGREFNMVTAENEMKIDATEPQRGQFNFSSADRVYNWAVQNGKQVRGHTLAWHSQQPGWMQSLSGSALRQAMIDHINGVMAHYKGKIVQWDVVNEAFADGSSGARRDSNLQRSGNDWIEVAFRTARAADPSAKLCYNDYNVENWTWAKTQAMYNMVRDFKQRGVPIDCVGFQSHFNSGSPYNSNFRTTLQNFAALGVDVAITELDIQGAPASTYANVTNDCLAVSRCLGITVWGVRDSDSWRSEQTPLLFNNDGSKKAAYTAVLDALNGGDSSEPPADGG,0.9937451571353184,C4001OD8,9.964332848340902,0.9937451571353184,10.21029111651832,0.0,999.0
121,1zog,2.3,2005,7.15,Ki=70nM,0.7212754613435847,5789,15,30.231889364278675,CRYSTAL STRUCTURE OF PROTEIN KINASE CK2 IN COMPLEX WITH TBB- 2 DERIVATIVES,MSKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQVRAAENSRTRA,1.0,C4001ZOG,30.11236166973789,1.0,31.058766062542,0.9701349233501995,30.94630189873509
122,2p7z,2.5,2008,6.58,Kd=0.262uM,0.8973091306024628,1773,29,11.623990514394077,ESTROGEN RELATED RECEPTOR GAMMA IN COMPLEX WITH 4-HYDROXY- 2 TAMOXIFEN,MGSSHHHHHHSSGLVPRGSHMPAKKPYNKIVSHLLVAEPEKIYAMPDPTVPDSDIKALTTLCDLADRELVVIIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDELVYADDYIMDEDQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANSDSMHIEDVEAVQKLQDVLHEALQDYEAGQHMEDPRRAGKMLMTLPLLRQTSTKAVQHFYNIKLEGKVPMHKLFLEMLEAKV,0.9999465793897008,C4002P7Z,24.629580202375344,0.9999465793897008,11.15656014635158,0.0,999.0
123,1lke,1.9,2003,7.52,Kd=30.2nM,0.97296288520307,1331,28,6.576273443446706,ENGINEERED LIPOCALIN DIGA16 IN COMPLEX WITH DIGOXIGENIN,DVYHDGACPEVKPVDNFDWSQYHGKWWQVAAYPDHITKYGKCGWAEYTPEGKSVKVSRYSVIHGKEYFSEGTAYPVGDSKIGKIYHSYTIGGVTQEGVFNVLSTDNKNYIIGYFCSYDEDKKGHMDLVWVLSRSMVLTGEAKTAVENYLIGSPVVDSQKLVYSDFSEAACKVNNSNWSHPQFEK,0.7240470415197472,C4001LKE,7.1326826653175806,0.7240470415197472,10.973212885852078,0.0,999.0
124,1lee,1.9,2002,7.74,Ki=18nM,0.7968362513744397,2993,39,8.313671323477605,CRYSTAL STRUCTURE OF PLASMEPSIN FROM P. FALCIPARUM IN COMPLEX WITH 2 INHIBITOR RS367,LGSSNDNIELVDFQNIMFYGDAEVGDNQQPFTFILDTGSANLWVPSVKCTTAGCLTKHLYDSSKSRTYEKDGTKVEMNYVSGTVSGFFSKDLVTVGNLSLPYKFIEVIDTNGFEPTYTASTFDGILGLGWKDLSIGSVDPIVVELKNQNKIENALFTFYLPVHDKHTGFLTIGGIEERFYEGPLTYEKLNHDLYWQITLDAHVGNISLEKANCIVDSGTSAITVPTDFLNKMLQNLDVIKVPFLPFYVTLCNNSKLPTFEFTSENGKYTLEPEYYLQHIEDVGPGLCMLNIIGLDFPVPTFILGDPFMRKYFTVFDYDNHSVGIALAKKNL,0.999926814085831,C4001LEE,8.482937062762534,0.999926814085831,8.527696666230508,0.0,999.0
125,2v95,1.93,2007,8.3,Kd=5.0nM,0.776825100501713,2938,26,16.20746292656077,STRUCTURE OF CORTICOSTEROID-BINDING GLOBULIN IN COMPLEX WITH 2 CORTISOL REVDAT   4   02-DEC-15 2V95    1       TITLE  REMARK VERSN,GSSNSHRGLAPTNVDFAFNLYQRLVALNPDKNTLISPVSISMALAMVSLGSAQTQSLQSLGFNLTETSEAEIHQSFQYLNYLLKQSDTGLEMNMGNAMFLLQKLKLKDSFLADVKQYYESEALAIDFEDWTKASQQINQHVKDKTQGKIEHVFSDLDSPASFILVNYIFLRGIWELPFSPENTREEDFYVNETSTVKVPMMVQSGSIGYFRDSVFPCQLIQMDYVGNGTAFFILPDQGQMDTVIAALSRDTIDRWGKLMTPRQVNLYIPKFSMSDTYDLKDVLEDLNIKDLLTNQSDFSGNTKDVPLTLTMVHKAMLQLDEGNVLPNSTNGAPLHLRSEPLDIKFNKPFILLLFDKFTWSSLMMSQVVNPA,0.9892670535161217,C4002V95,38.58419904807245,0.9892670535161217,15.69209198066356,0.9763424002501357,17.053018994928433
126,3b66,1.65,2008,8.6,Ki=2.5nM,1.0590782101898852,2205,29,8.583472611056848,CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING 2 DOMAIN IN COMPLEX WITH SARM S-21,PIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ,0.994021062628511,C4003B66,8.623789303626163,0.994021062628511,8.202810890510447,0.9795521007469338,8.416277472389638
127,2f1g,1.9,2006,7.54,Ki=29nM,0.7071767518226442,1907,32,12.420601594162983,CATHEPSIN S IN COMPLEX WITH NON-COVALENT 2-(BENZOXAZOL-2-YLAMINO)- 2 ACETAMIDE,NRILPDSVDWREKGCVTEVKYQGSCGACWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEI,0.9967985787878296,C4002F1G,12.422983147764937,0.9967985787878296,12.330607078678907,0.9792433300316814,12.479795264271571
128,2exm,1.8,2005,4.11,Ki=78uM,0.7984099778424669,2512,15,12.877383118768106,HUMAN CDK2 IN COMPLEX WITH ISOPENTENYLADENINE,MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL,0.991042896364266,C4002EXM,12.96029564447811,0.991042896364266,12.251170309798626,0.9576840983310309,12.846475208381042
129,1vyf,1.85,2004,8.05,Kd=9nM,0.741090032791994,1240,20,6.386027289618679,SCHISTOSOMA MANSONI FATTY ACID BINDING PROTEIN IN COMPLEX 2 WITH OLEIC ACID,GSMSSFLGKWKLSESHNFDAVMSKLGVSWATRQIGNTVTPTVTFTMDGDKMTMLTESTFKNLSCTFKFGEEFDEKTSDGRNVKSVVEKNSESKLTQTQVDPKNTTVIVREVDGDTMKTTVTVGDVTAIRNYKRLS,0.9927529142783544,C4001VYF,6.586834612306404,0.9927529142783544,5.606537409645036,0.961924323890357,6.557079373126839
130,2j7g,1.91,2006,7.0,Kd=100nM,0.877662653905387,4012,18,6.073727725375258,BETA-GLUCOSIDASE FROM THERMOTOGA MARITIMA IN COMPLEX WITH 2 METHYL ACETIC ACID-SUBSTITUTED GLUCOIMIDAZOLE,MGSSHHHHHHSSGLVPRGSHMASNVKKFPEGFLWGVATASYQIEGSPLADGAGMSIWHTFSHTPGNVKNGDTGDVACDHYNRWKEDIEIIEKLGVKAYRFSISWPRILPEGTGRVNQKGLDFYNRIIDTLLEKGITPFVTIYHWDLPFALQLKGGWANREIADWFAEYSRVLFENFGDRVKNWITLNEPWVVAIVGHLYGVHAPGMRDIYVAFRAVHNLLRAHARAVKVFRETVKDGKIGIVFNNGYFEPASEKEEDIRAVRFMHQFNNYPLFLNPIYRGDYPELVLEFAREYLPENYKDDMSEIQEKIDFVGLNYYSGHLVKFDPDAPAKVSFVERDLPKTAMGWEIVPEGIYWILKKVKEEYNPPEVYITENGAAFDDVVSEDGRVHDQNRIDYLKAHIGQAWKAIQEGVPLKGYFVWSLLDNFEWAEGYSKRFGIVYVDYSTQKRIVKDSGYWYSNVVKNNGLED,0.5337592022749708,C4002J7G,22.25534694618404,0.5337592022749708,27.13051073985412,0.0,999.0
131,1e2l,2.4,2000,4.29,Ki=51.5uM,1.0485313688212927,4852,18,18.39764454933432,KINETICS AND CRYSTAL STRUCTURE OF THE WILD-TYPE AND THE 2 ENGINEERED Y101F MUTANT OF HERPES SIMPLEX VIRUS TYPE 1 3 THYMIDINE KINASE INTERACTING WITH 4 (NORTH)-METHANOCARBA-THYMIDINE,MPTLLRVYIDGPHGMGKTTTTQLLVALGSRDDIVYVPEPMTYWRVLGASETIANIFTTQHRLDQGEISAGDAAVVMTSAQITMGMPYAVTDAVLAPHIGGEAGSSHAPPPALTLIFDRHPIAALLCYPAARYLMGSMTPQAVLAFVALIPPTLPGTNIVLGALPEDRHIDRLAKRQRPGERLDLAMLAAIRRVYGLLANTVRYLQCGGSWREDWGQLSGTAVPPQGAEPQSNAGPRPHIGDTLFTLFRAPELLAPNGDLYNVFAWALDVLAKRLRSMHVFILDYDQSPAGCRDALLQLTSGMVQTHVTTPGSIPTICDLARTFAREMGEAN,0.9944385044102144,C4001E2L,18.40180027602401,0.9944385044102144,17.10801581645383,0.9827067362832054,19.0680975103143
132,2e7f,2.2,2007,6.1,Kd=0.79uM,0.7107314552578048,4464,33,21.33580627327564,5-METHYLTETRAHYDROFOLATE CORRINOID/IRON SULFUR PROTEIN 2 METHYLTRANSFERASE COMPLEXED WITH METHYLTETRAHYDROFOLATE TO 3 2.2 ANGSROM RESOLUTION,MLIIGERINGMFGDIKRAIQERDPAPVQEWARRQEEGGARALDLNVGPAVQDKVSAMEWLVEVTQEVSNLTLCLDSTNIKAIEAGLKKCKNRAMINSTNAEREKVEKLFPLAVEHGAALIGLTMNKTGIPKDSDTRLAFAMELVAAADEFGLPMEDLYIDPLILPANVAQDHAPEVLKTLQQIKMLADPAPKTVLGLSNVSQNCQNRPLINRTFLAMAMACGLDAAIADACDEALIETAATAEILLNQTVYCDSFVKMFKTR,0.9887966432414194,C4002E7F,22.63038078100567,0.9887966432414194,23.624472395704384,0.9784174851500489,29.125019115232814
133,1bgq,2.5,1999,8.57,Kd=2.7nM,0.8232612183920766,3607,25,20.851389218241984,RADICICOL BOUND TO THE ATP BINDING SITE OF THE N-TERMINAL 2 DOMAIN OF THE YEAST HSP90 CHAPERONE,MRGSHHHHHHGMASETFEFQAEITQLMSLIINTVYSNKEIFLRELISNASDALDKIRYKSLSDPKQLETEPDLFIRITPKPEQKVLEIRDSGIGMTKAELINNLGTIAKSGTKAFMEALSAGADVSMIGQFGVGFYSLFLVADRVQVISKSNDDEQYIWESNAGGSFTVTLDEVNERIGRGTILRLFLKDDQLEYLEEKRIKEVIKRHSEFVAYPIQLVVTKEVE,0.9782746866416622,C4001BGQ,20.89374403706132,0.9782746866416622,21.88910832190392,0.9692384964470663,20.995920569591647
134,1ta6,1.9,2004,9.13,Ki=0.74nM,0.8029074241011024,2407,33,13.725254951412298,CRYSTAL STRUCTURE OF THROMBIN IN COMPLEX WITH COMPOUND 14B,DCGLRPLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG,0.5979097480645846,C4001TA6,41.70073921832962,0.5979097480645846,41.75236420577947,0.0,999.0
135,1h22,2.15,2002,9.1,Ki=0.8nM,0.876322280287965,4428,34,12.058581739298212,"STRUCTURE OF ACETYLCHOLINESTERASE (E.C. 3.1.1.7) COMPLEXED WITH (S,S)- 2 (-)-BIS(10)-HUPYRIDONE AT 2.15A RESOLUTION",DDHSELLVNTKSGKVMGTRVPVLSSHISAFLGIPFAEPPVGNMRFRRPEPKKPWSGVWNASTYPNNCQQYVDEQFPGFSGSEMWNPNREMSEDCLYLNIWVPSPRPKSTTVMVWIYGGGFYSGSSTLDVYNGKYLAYTEEVVLVSLSYRVGAFGFLALHGSQEAPGNVGLLDQRMALQWVHDNIQFFGGDPKTVTIFGESAGGASVGMHILSPGSRDLFRRAILQSGSPNCPWASVSVAEGRRRAVELGRNLNCNLNSDEELIHCLREKKPQELIDVEWNVLPFDSIFRFSFVPVIDGEFFPTSLESMLNSGNFKKTQILLGVNKDEGSFFLLYGAPGFSKDSESKISREDFMSGVKLSVPHANDLGLDAVTLQYTDWMDDNNGIKNRDGLDDIVGDHNVICPLMHFVNKYTKFGNGTYLYFFNHRASNLVWPEWMGVIHGYEIEFVFGLPLVKELNYTAEEEALSRRIMHYWATFAKTGNPNEPHSQESKWPLFTTKEQKFIDLNTEPMKVHQRLRVQMCVFWNQFLPKLLNATACDGELSS,0.8601596303663671,C4001H22,14.56909322937439,0.8601596303663671,14.224805959386574,0.0,999.0
136,2boh,2.2,2006,8.52,Ki=3nM,0.8321817583258446,2504,33,16.69226138179472,"CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND ""1"" REVDAT   3   29-JAN-14 2BOH    1       TITLE  REMARK VERSN  HETSYN",EEMKKGHLERECMEETCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLER,0.9887135691452116,C4002BOH,16.868113603511237,0.9887135691452116,16.678152278810007,0.9691568193459599,17.879584411393115
137,3d7z,2.1,2008,7.92,Ki=12nM,0.971609295919833,3209,26,9.865896692840147,CRYSTAL STRUCTURE OF P38 KINASE IN COMPLEX WITH A BIPHENYL AMIDE 2 INHIBITOR,MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES,0.9953087137124008,C4003D7Z,9.884303909271267,0.9953087137124008,9.741879572238826,0.9738772461566597,10.143582028409032
138,2psv,1.75,2007,7.24,Ki=58nM,0.9272223864138328,1716,33,4.984362094406492,CRYSTAL STRUCTURE OF WILD TYPE HIV-1 PROTEASE IN COMPLEX WITH CARB- 2 KB45,PQITLWKRPLVTIRIGGQLKEALLDTGADDTVLEEMNLPGKWKPKMIGGIGGFIKVRQYDQIPIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF,0.9941926252237592,C4002PSV,5.257820998025093,0.9941926252237592,5.232543889919423,0.9709526416257949,4.857385074902876
139,3f8f,2.2,2008,6.63,Kd=236nM,0.4879480640311017,1913,38,5.04737408574047,CRYSTAL STRUCTURE OF MULTIDRUG BINDING TRANSCRIPTIONAL REGULATOR LMRR 2 COMPLEXED WITH DAUNOMYCIN,MAEIPKEMLRAQTNVILLNVLKQGDNYVYGIIKQVKEASNGEMELNEATLYTIFKRLEKDGIISSYWGDESQGGRRKYYRLTEIGHENMRLAFESWSRVDKIIENLEANKKSEAIKSRWSHPQFEK,0.4831074707744671,C4003F8F,13.5022501227416,0.4831074707744671,6.735372742423215,0.0,999.0
140,1ele,2.0,1995,6.85,Ki=0.14uM,0.7044020550029166,1989,29,13.376686028158607,STRUCTURAL ANALYSIS OF THE ACTIVE SITE OF PORCINE PANCREATIC ELASTASE 2 BASED ON THE X-RAY CRYSTAL STRUCTURES OF COMPLEXES WITH 3 TRIFLUOROACETYL-DIPEPTIDE-ANILIDE INHIBITORS,VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCVDRELTFRVVVGEHNLNQNNGTEQYVGVQKIVVHPYWNTDDVAAGYDIALLRLAQSVTLNSYVQLGVLPRAGTILANNSPCYITGWGLTRTNGQLAQTLQQAYLPTVDYAICSSSSYWGSTVKNSMVCAGGDGVRSGCQGDSGGPLHCLVNGQYAVHGVTSFVSRLGCNVTRKPTVFTRVSAYISWINNVIASN,0.9961583601835904,C4001ELE,13.095439767866528,0.9961583601835904,12.515433028437348,0.966305492360753,13.147354804037201
141,1hmt,1.4,1995,5.79,Kd=1.64uM,0.7715577658398385,1238,20,6.883783920168359,1.4 ANGSTROMS STRUCTURAL STUDIES ON HUMAN MUSCLE FATTY ACID BINDING 2 PROTEIN: BINDING INTERACTIONS WITH THREE SATURATED AND UNSATURATED 3 C18 FATTY ACIDS,VDAFLGTWKLVDSKNFDDYMKSLGVGFATRQVASMTKPTTIIEKNGDILTLKTHSTFKNTEISFKLGVEFDETTADDRKVKSIVTLDGGKLVHLQKWDGQETTLVRELIDGKLILTLTHGTAVCTRTYEKEA,0.9914246488106124,C4001HMT,7.200491645054422,0.9914246488106124,6.737367167866616,0.9709698073127621,5.704360258308965
